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Metal neurotoxicity is a global health concern. This paper summarizes the evidence for metal interactions with synaptic
transmission and synaptic plasticity. Presynaptically metal ions modulate neurotransmitter release through their interaction with
synaptic vesicles, ion channels, and the metabolism of neurotransmitters (NT). Many metals (e.g., Pb2+, Cd2+,a n dHg+)a l s o
interact with intracellular signaling pathways. Postsynaptically, processes associated with the binding of NT to their receptors,
activation of channels, and degradation of NT are altered by metals. Zn2+, Pb2+, Cu2+, Cd2+, Ni2+, Co2+, Li3+, Hg+,a n d
methylmercury modulate NMDA, AMPA/kainate, and/or GABA receptors activity. Al3+, Pb2+, Cd2+,a n dAs2O3 also impair
synaptic plasticity by targeting molecules such as CaM, PKC, and NOS as well as the transcription machinery involved in the
maintenance of synaptic plasticity. The multiple eﬀects of metals might occur simultaneously and are based on the speciﬁc metal
species, metal concentrations, and the types of neurons involved.
1.Introduction
Metals and their compounds are distributed in ecosystems
as a result of natural processes as well as anthropogenic
activities. Metals are used in their elementary form as well as
in compounds for various human needs. Therefore, a num-
ber of these metals enter our environment as a consequence
of their widespread use in preservatives, biocides, and paints
[1]. They are taken up by organisms through inhalation or
by ingestion of food and water contaminated with these
metals. For living systems, metals can be divided in those
which are essential for life, such as cobalt (Co), copper
(Cu), zinc (Zn), manganese (Mn), and iron (Fe); which are
potentially toxic only at higher concentration, and those
whichhavenoknownbiologicalfunction,whichcanbetoxic
atallconcentrationssuchascadmium(Cd),chromium(Cr),
mercury (Hg), and lead (Pb) [13] (for all abbreviations used
in the review please refer to the abbreviations section; to
facilitate reading, the names of the speciﬁc metals discussed
are given in italics).
Since the uptake mechanisms of the body are not
able to distinguish between “physiologically required” and
harmful metals, the toxic metals absorbed consequently
might interact with the functions of the central nervous
system (CNS), liver, kidneys, and hematopoietic system, thus
presenting a signiﬁcant health hazard. In this review, we will
examine the eﬀects of these metals in the CNS, speciﬁcally at
the synapse.
The human brain has about 1011 neurons, which in-
terconnect and “communicate” with each other through
synapses. It is estimated that each neuron has approximately
7000 synapses. At the presynaptic side of the synapse the
incoming electrical signal, in from of action potentials, is
transformed to a chemical signal in the form of neurotrans-
mitter release. Synaptic transmission depends on the timely
opening of membrane channels, the precise functioning of
intracellular signaling pathways, and metabolic pathways
involved in the synthesis and the release of neurotrans-
mitters. Postsynaptically the binding of neurotransmitters
changes the membrane potential, resulting in a hyper- or
depolarization of the neuron and in the generation of an
action potential when the threshold potential is reached.
These are crucial process and the basis of all higher cognitive
functions including learning and memory.2 Journal of Toxicology
Therefore, we highlight the mechanisms by which metals
and their compounds interfere with the processes of synaptic
transmission and synaptic plasticity. This review covers the
eﬀects of metals on signal transmission from the presynaptic
to the postsynaptic membrane, as well as the eﬀects on
synaptic plasticity with an emphasis on learning and mem-
ory, since subtle alterations in synaptic transmission due to
the interaction of metals may have profound toxic eﬀects in
the CNS [14].
Some metals, which have already been shown to alter
synaptic transmission, are discussed in this review. The
metals are listed in an alphabetical order below with a short
description of their neurotoxic eﬀects, to show their rel-
evance to this study (for more details regarding the neuro-
toxicity of these metals see [15]).
Aluminum was found present in high concentrations
in brains of patients with Alzheimer’s disease, Parkin-
son’s disease, and dialysis encephalopathy and could con-
tribute to neurogenerative disorders [21]. In animals the
administration of aluminum salts results in neuroﬁbrillary
degeneration, a condition similar to the encephalopathy in
Alzheimer’s disease [3].
Arsenic, one of the oldest known poisons, due to its
cholera-like symptoms, became a favorite poisoning agent
and earned the title the “Poison of Kings” [15]. An acute
ingestion of arsenic aﬀects many systems of the body in-
cluding gastrointestinal, cardiovascular, respiratory, and the
nervous system. Even today, chronic low-dose exposure
to arsenic is very common in countries like Bangladesh,
India, Taiwan, and other parts of South East Asia due to
contamination of groundwater by arsenic.I ti sam a j o r
cause of infant mortality in Bangladesh [8]. Chronic man-
ifestations of arsenic poisoning are pigmentation changes,
gastrointestinal problems, anemia, liver disease, black foot
disease, and Mees’ lines on the nails. Central neuropathy
due to Arsenic poisoning usually manifests as impairment of
learning, short-term memory and concentration. However,
peripheral neuropathy is more frequently observed and this
might last for several years. It manifests as a rapid and severe
ascending weakness and sometimes these patients require
mechanical ventilation [8, 15].
Cadmium and manganese also have neurotoxic eﬀects,
where cadmium damages cells of the cerebellar cortices of
y o u n gr a t sa sw e l la sr a b b i t sa n dc h r o n i cmanganese poi-
soning causes extrapyramidal symptoms much like those of
Wilson’s disease and Parkinsonism [9]. Moreover, increased
total cadmium levels in human hair were associated with
mental retardation and impairment in visual motor abilities
[4]. Similar toxicities also occur in humans.
Lead, whose mechanisms of neurotoxicity have been
extensively studied, was discovered more than 5000 years ago
and was used in the ancient world for lead water piping,
as utensils, to sweeten food and wine, and as a constituent
of eye paints [2]. It was discovered that acute exposure to
Pb could cause lead colic and mental disturbances and even
chronic exposure to low concentrations of lead in children
caused several cognitive and behavioral disturbances. Since
Pb crosses the placenta, prenatal exposure to lead can have
especially severe consequences [4, 5, 15].
Exposure to dietary methylmercury leads to Minamata
disease,whichmanifestedinpatientsasparesthesiasfollowed
by irreversible impairment of vision, hearing, speech, gait,
and ultimately leads to death. In addition, cognitive impair-
ment ensued with prenatal exposure to methylmercury [4].
Organo-tins are industrially produced in large quantities
for applications as PVC stabilizers, glass coverings, silicone,
wood preserver additives, and antifouling paints. Moreover,
considerable amounts of organo-tins are released in the
environment causing large concern about their impact on
human health. Due to their lipophilicity organo-tins are
taken up by humans and distributed in diﬀerent tissues. In
mammalian organs such as brain, liver, and kidneys, organo-
tins are biotransformed and this process may increase their
toxicity [7]. Speciﬁcally alkyl-tins have been shown to cause
neurotoxicity [15].
Even though metals are well known for their various
toxicities, they are also used as therapeutic agents. Lithium
salts have been used in the treatment and prophylaxis of
bipolar aﬀective disorder [10, 16]. Arsenic in the form of
arsenic trioxide is used for the treatment of leishmaniasis,
leukemia, and trypanosomiasis [8, 15]. The speciﬁc toxicities
of some metals are actuallybeing used to man’s beneﬁt, espe-
cially for the treatment of cancers. Cisplatin (cis-diammine-
dichloro-platin = CDDP) is used as an anticancer drug
and testicular cancer, endometrial cancer, prostatic tumors,
bladder carcinoma, and small cell bronchial carcinoma [17]
are successfully treated with this drug.
With the wide description of harmful eﬀects of metals
as well as their irreplaceability in modern life and medicine,
it becomes essential to demarcate the level at which metals
become toxic. This includes concentrations of metals as
well as their targets of actions. Recognizing the targets sites
at which metals interact can serve as a stepping-stone for
the development of therapeutic agents to counteract metal
toxicity as well as the side eﬀects of anticancer drugs such as
arsenic and cisplatin compounds.
This paper aims to review the literature available of the
mechanisms of actions of metals at targets presynaptically,
postsynaptically, and on long-term potentiation (LTP) and
summarizes the ﬁndings in a logical and easily comprehensi-
ble manner. In the ﬁrst part the toxic eﬀects of organic and
inorganic metals on the presynaptic part will be described
(Section 2),followedbyareviewoftheirpostsynapticactions
(Section 3), and the review ﬁnally looks at the impairment
of synaptic plasticity (Section 4) before concluding remarks
are made (Section 5).
2.PresynapticTargets of ToxicMetals
Presynaptically, the action potential, which is an electrical
signal, is transduced to a chemical signal in the form
of neurotransmitter release. Generally, the action potential
induces a membrane depolarization, which opens voltage
gated calcium channels allowing the inﬂux of Ca2+.C a 2+
activates calmodulin (CaM) and therefore CaM kinases
(CamK) are activated, which leads to the phosphorylationJournal of Toxicology 3
of synaptic vesicle associated proteins and the conver-
sion of the reserve pool of synaptic vesicles to a readily
releasable pool of vesicles. Ca2+ also binds synaptotagmin,
a calcium sensor protein in the vesicle membrane and
triggers neurotransmitter vesicle fusion and the release of
neurotransmitter [18]( Figure 1).
Metals interact with speciﬁc targets in these pathways
and the same metals might even interact with various targets
simultaneously. For instance, aluminum blocks voltage gated
calcium channels, decreases the biological activity of CaM,
and also inhibits Ca2+ ATPase [19, 20]. In addition, if a
metal interacts with an upstream target of a pathway, it
may inﬂuence all the processes succeeding it. For example,
cadmium r e d u c e sv o l t a g ea c t i v a t e dc a l c i u mc h a n n e lc u r -
rents, therefore, it can inﬂuence the intracellular calcium
concentration and consequently the activation of CaM and
calcium-dependent intracellular signaling pathways [6, 11].
Notably, cadmium caused a decrease in release of excitatory
neurotransmittersglutamateandaspartatewhileitcausedan
increase in the release of inhibitory neurotransmitters GABA
and glycine [12].
The upcoming sections (Sections 2.1 to 2.6) highlight
the literature relating to the toxic eﬀects of metals on
presynaptic targets including voltage-activated ion chan-
nels (Section 2.1), signaling cascades (Section 2.2), trans-
porters (Section 2.3), synaptic vesicle associated proteins
(Section 2.4), neurotransmitters (Section 2.5), and neuroﬁl-
aments and microtubules (Section 2.6). For ease of access,
wherever possible metals are described in alphabetical order
in each Section.
2.1. Voltage-Activated Channels
2.1.1. Voltage-Activated Calcium Channels. Voltage activated
calcium channels open by a depolarization. They are sub-
divided into high- and low-voltage activated channels. The
high-voltage activated channels, which have to be depolar-
ized to more positive voltages than −30mV for activation,
include the L-type, P/Q-type, N-type, and R-type, where
the L-type has a “long-lasting” current. The other types
are divided on the basis of their inactivation and their
susceptibility to various peptide toxins. There are also low-
voltage activated channels which are mainly composed of
the T-type channels which have a small, fast inactivating and
therefore transient current [22].
Aluminum (Al3+) blocked N- and L-type voltage acti-
vated calcium channels in cultured rat dorsal root ganglions,
with a threshold concentration of 20μM and a Hill’s
coeﬃcientof3 (Table 1).Italsorequiredanopenchannel for
itsactionstherebyindicatingthatthepossiblesiteofactionof
Al3+ was inside the channel. The current-voltage relation was
shifted to depolarizing voltages in the presence of Al3+ [19].
Aluminum also blocked voltage-activated calcium channels
in vivo in rats when given 10mg per kg body weight per day
intraperitoneally for 4 weeks. Inhibition was nearly 85% in
the corpus striatum, 58% in the cerebral cortex, and 46% in
the hippocampus [20].
Cadmium (Cd2+) eﬀectively reduced voltage-activated
calciumchannelcurrents,whichwerehighthresholdandfast
inactivatingtypesinculturedchickdorsalrootganglioncells,
at concentrations of 20μM. This block was released at hyper-
polarizing voltages, which may be due to shifts in gating and
permeability of the channels. When the membrane potential
was hyperpolarized, the channels conducted transiently, as
Cd2+ exited the channels, but closed again thereafter. The
channels can close with Cd2+ in the channel pore, therefore
implying that Cd2+ does not aﬀect the closing mechanisms
of the channels [6]. Similar results were obtained in squid
giant ﬁber neurons. In addition, a kinetic model was created
and the binding site for Cd2+ was determined to be near the
outer end of the pore, and the entry of Cd2+ into the pore
was voltage independent while its exit was voltage dependent
[11].
Lead (Pb2+) is a potent blocker of voltage-activated
calcium channels in invertebrate Aplysia n e u r o n sa sw e l la s
in mammalian neurons [19, 23, 25, 27, 28, 30]. There is no
change in the voltage dependence of activation or inactiva-
tion of the channels in mammalian neurons, which suggests
an external binding site for Pb2+ [25, 27, 28]. In mammals
Pb2+ blocked N-, L- and T-type voltage activated calcium
channels[19,27,28,30].TheblockofL-andT-typechannels
was concentration dependent and reversible in N1E-115
mouse neuroblastoma cells [30]. The concentration for 50%
inhibition (IC50) of L-type channels was 30nM, and for N-
type channels it was 80nM free Pb2+ where 10mM Ba2+ was
used as the charge carrier in cultured E-18 rat hippocampal
neurons [28]. Some contradictory data were obtained in a
study of mouse N1E-115 neuroblastoma cells, where in ﬁve
of the ﬁfteen cells studied, 2.3μM Pb2+ enhanced L-type
calcium channel currents and also enhanced the inactivation
of L-type channels at holding potentials of −60 to −40
mV [30]. A study on human neuroblastoma cells SH-SY5Y
determined that lead acetate at concentrations of 1 to 30
μM blocked voltage-activated calcium channels, both N- and
L-types in a concentration-dependent and reversible way.
More importantly, the concentrations used in the study were
inclusive of the blood level concentrations at which children
present with neuropsychological disorders (between 1.5–2.5
μM) [29].
Mercury (Hg2+) blocked voltage-activated calcium chan-
nels with an IC50 of 1.1 μM in vitro in rat pup dorsal root
ganglion cells, and it required a partially open channel for its
block [24]. Mercury (Hg2+) blocked neuronal N- and R-type
calcium channels transiently expressed in human embryonic
kidney 293 cells with an IC50 of 2.2 and 0.7μM. This eﬀect
was partially reversible in N-type but not in R-type channels
[26]. Mercury also blocked T-type calcium channel currents
in the concentration range of 0.5–2μM in cultured rat dorsal
root ganglion cells. In addition the current-voltage relation
was shifted to positive voltages implying that mercury may
have an eﬀect on channel gating [40].
Platinum in the form of cis-diammine-dichloro-platin
(CDDP) reduced voltage-activated calcium channel currents
in dorsal root ganglion cells of rats in vitro. CDDP reduced
peak calcium current with an IC50 of 23.9 ± 4.5μMa n d
sustained current with an IC50 of 38.8 ± 6.1μMi ns m a l l4 Journal of Toxicology
Figure 1: Presynaptic targets of neurotoxic metals. Events at the synapse from the arrival of the action potential which results in
the membrane depolarization-induced opening of voltage-activated calcium channels and the entry of calcium which activates CaM,
which activates CaM kinases and causes the phosphorylation of synaptic vesicle-associated proteins and an increase in readily releasable
neurotransmitter vesicles. Calcium also binds synaptotagmin and causes exocytosis of neurotransmitter from the vesicles. Shown in boxes
are the metals and the targets at which they act in the synaptic transduction pathway. A table at the end indicates the symbols and what
they indicate. Green indicates activation or upregulation while red indicates inhibition or downregulation. Please refer to the section of
Abbreviations and metals.Journal of Toxicology 5
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neurons with a diameter of ≤20μm. Surprisingly, in large
neurons with a cross-sectional diameter of ≥25μm, the peak
calcium current was only reduced by 14.1 ± 2.3% even
with a concentration of 100μM CDDP. It is unlikely that
the voltage-activated calcium channel currents were blocked
directlysincethesmallandlargecellswereunequallyaﬀected
andtheHill’scoeﬃcientwasnot1.CDDP probablydecreases
voltage-activatedcalciumchannelcurrentsbyactingthrough
an intracellular pathway more prominent in small neurons,
possibly through IP3 receptor activation as described later
[17].
Tin (Sn2+) used as stannous chloride (SnCl2) decreased
voltage-activated calcium channel currents in vitro in rat
dorsal root ganglion cells in a concentration-dependent
manner with a threshold of 1μM. These eﬀects were found
to be irreversible [41]. However, contradictory results were
obtained in a study of motor nerve terminals of frog, where
nerve muscle preparations were exposed to 50μM SnCl2,
which caused an increased inward Ca2+ current [34].
Zinc (Zn2+) blocked voltage-activated calcium channels
in cultured rat dorsal root ganglion cells [19, 24, 31]. The
IC50 for this eﬀect on N- and L-type channels was 69μM
Zn2+ while the Hill’s coeﬃcient was 1. T-type currents were
more sensitive, and the block was partly reversible in 50%
of the neurons [31]. Zinc did not require an open channel
for this blocking eﬀect [24]. The current voltage relationship
shifted to more depolarizing voltages in the presence of Zn2+,
implying that the mechanism of action of Zn2+ may involve
the screening of charges in the vicinity of the channels [19].
Methylmercury (MeHg) caused an increase in calcium
inﬂux and therefore [Ca2+]i through nifedipine and ω-
conotoxin sensitive mechanisms, that is, through either, L-,
N-, or Q-type calcium channels [36]. However, methylmer-
cury caused an irreversible time and concentration depen-
dent block of calcium channel currents at concentrations
between 0.25 and 1μM in vitro in rat cerebellar granule
neurons. The block did not require depolarization, indicat-
ing that it did not require an open channel. Increasing the
frequency of stimulation of cells increased the magnitude of
block at 0.25μMa n d0 . 5 μMb u tn o ta t1 μM, which may
suggest the presence of other counteracting eﬀects. None of
the calcium channel antagonists used—ω-conotoxin GVIA,
ω-conotoxin MVIIC, ω-agatoxin IVA, calcicludine, and
nimodipine, were able to decrease the MeHg-induced block
of calcium channel currents [38]. MeHg blocked N-, R-, and
L-type voltage-activated calcium channels [26, 39]. MeHg
blocked human neuronal N- and R- type calcium channel
currents transiently expressed in human embryonic kidney
293 cells with an IC50 of 1.3μMa n d1 . 1 μMr e s p e c t i v e l y
(Table 4). This block was determined to be irreversible [26].
Trimethyl lead blocked voltage-activated calcium chan-
nels with a threshold concentration of 0.5μM in vitro in
rat dorsal root ganglion cells. This block was irreversible
and concentration dependent but not voltage dependent. It
required an open channel and the IC50 was between 1–5μM
[33].
2.1.2. Voltage-Activated Sodium Channels. There are 9
subtypes of voltage-activated sodium channels Nav 1.1–Nav
1.9distinguishedbytheirsensitivitytotetrodotoxinandtheir
rateofinactivation.Nav 1.8andNav 1.9haverelativelyslower
inactivation [35]. Nav 1.1, Nav 1.2, Nav 1.3, and Nav 1.7 are
expressedinneuronsandarehighlysensitivetotetrodotoxin.
Nav 1.5, Nav 1.8, and Nav 1.9 are relatively tetrodotoxin
r e s i s t a n ta n da r ef o u n di nh e a r ta n dd o r s a lr o o tg a n g l i o n
neurons. Nav 1.4 and Nav 1.6 are mostly expressed in skeletal
muscle and the CNS, respectively [37].
Zinc (Zn2+) and cadmium (Cd2+) reduced both tet-
rodotoxin-sensitive and tetrodotoxin-insensitive voltage-
activated sodium channel currents in voltage clamp exper-
iments in neuronal, cardiac, and skeletal muscle cells [42].
Tetrodotoxin-resistant channels were more sensitive to Zn2+
and Cd2+ with IC50 of the block being 50μMa n d0 . 2m M ,
respectively; tetrodotoxin-sensitive channels were less resis-
tant with IC50 of the block being 2mM and 5mM for Zn2+
and Cd2+,r e s p e c t i v e l y[ 42]( c o m p a r ee ﬀects in Table 1). It
was suggested that the site of action of Zn2+ contains cysteine
sulfhydryl groups in or near the saxitoxin binding site since
Zn2+ was able to relieve the saxitoxin-induced block of the
channel in a competitive manner, and the blocking action of
zinc was inhibited by sulfhydryl-speciﬁc alkylating reagents.
These experiments were done in voltage-activated sodium
channels taken from the hearts of dogs or calves [32].
SnCl2 had an eﬀect on voltage-activated sodium channel
currents of the mollusk Lymnaea stagnalis in vitro where
it shifted the current voltage curve to the left. SnCl2
increased voltage-activated sodium channel currents at a
concentration of 10μM, but caused a depression in current
at concentrations above 25μM. Organic tin in the form of
(CH3)3SnCl decreased signiﬁcantly the Na current only at
high concentrations above 100μM. Additionally the current
voltage curve was shifted to the left. These eﬀects were time
dependent and irreversible [43].
Cobalt, manganese, nickel, calcium, magnesium, stron-
tium, and barium in divalent cation form blocked both
tetrodotoxin-sensitive and tetrodotoxin-insensitive channels
in channels incorporated into planar bilayers in the presence
of batrachotoxin. The block was voltage dependent and the
sequence of aﬃnity to block was Co2+∼ = Ni2+>Mn2+> Ca2+>
Mg2+> Sr2+> Ba2+. The suggested mechanisms of block
included a speciﬁc divalent cation binding site and surface
charge screening [44]. Also 10μM of the anticancer drug
CDDPreducedvoltage-activatedsodiumchannelcurrentsby
9.2%± 7.2% in rat dorsal root ganglions in vitro [17].
2.1.3. Voltage-Activated Potassium Channels. The family of
voltage-activated potassium channel includes Kv1–6, Kv 8,
and Kv 9, where the principal subunit of the channels
contains 6 transmembrane domains. All these channels
are expressed in brain tissue [45]. Whole cell patch-clamp
measurements of transient voltage-dependent potassium
currents in rat suprachiasmatic nucleus neurons showed that
Zn2+ potentiated current when activated from a holding
potential of −60mV (approximately the resting membrane
potential). This potentiation was voltage dependent and
arose from a shift of the inactivation current to more
positive voltages. Zn2+ (30μM) shifted the half-inactivation
voltage by 20mV from −80mV to −60mV [46]. Kuo andJournal of Toxicology 7
Chen showed that at hyperpolarized voltages Zn2+ inhibited
voltage-dependent transient K+ currents which can be
accounted for by the selective binding of Zn2+ to closed K+-
channelswithadissociationconstantofapproximately3μM,
which kept the channels closed and slowed the activation of
the current [47].
Whole cell patch clamp studies in central neurons of
Drosophila third instar larvae showed that millimolar Ca2+
and Mg2+ concentrations and micromolar concentrations
of Zn2+ increased the peak inactivation current and shifted
thesteady-stateinactivationcurveofvoltagegatedpotassium
channels to more positive voltages, but had no eﬀect
on the voltage dependence of activation. A micromolar
concentration Cd2+ had the same eﬀect; however, millimolar
concentrations of Cd2+ had an eﬀect on both steady state
inactivationandactivationcurves,wherethemidpointofthe
activation curve was shifted more positively. The potency of
eﬀect on the inactivation current in terms of amount of shift
of steady state inactivation curves was Zn2+ (2mM) >Cd2+
(2mM) >Ca2+ (20mM) >Mg2+ (20mM). The mechanism
of action was most likely through speciﬁc binding to the
channels at extracellular sites [48].
10μM cisplatin in the form of CDDP reduced voltage-
gated potassium channel currents by 20.9 ± 4.8% in small
dorsal root ganglion neurons while 100μM CDDP reduced
the peak current by 12.8 ± 3.4% [17]. Micromolar con-
centrations of lanthanum (La3+) enhanced outward voltage-
gated potassium channel currents evoked by depolarization
steps from −50mV in rat cerebellar granule neurons. 10μM
La3+ shifted the steady state inactivation curve by approxi-
mately40mVinthedepolarizing directionandincreasedthe
slope factor slightly [49].
Mayer and Sugiyama showed that fast activating tran-
sient potassium channel currents were reduced by 10 mM
manganese (Mn2+) in cultured rat sensory neurons. This
reduction was due to a depolarizing shift of the activation
curve and a slight reduction in maximum conductance. At
the same concentration, steady state inactivation curves were
also shifted to depolarizing voltages. The positive shift of
steady state inactivation and activation curves were obtained
for other metals as well, where the potency of shift was
Cd2+ >Mn2+ =C o 2+ >Ca2+ > Mg2+. Lower concentrations
of Mn2+ (1mM), however, increased the amplitude of fast
inactivatingtransientpotassiumchannelcurrentsatprepulse
potentials from −50 to −70mV, which was due to a shift
of the inactivation curve with no signiﬁcant shift in the
activation curve. These eﬀects may have been due to binding
to a speciﬁc site within the channel or to phospholipids in
close proximity of the gating apparatus [50].
Organic metals also aﬀect voltage-gated potassium chan-
nels. Methylmercury (MeHg) blocked voltage-gated potas-
sium channels irreversibly, with an IC50 of 2.2 ± 0.3μMi n
a concentration-dependent manner. The Hill’s coeﬃcient for
this block was ∼1[ 51].
2.2. Signaling Cascades
2.2.1. The cAMP System. G-protein-coupled receptors
(GPCR) are coupled to Gs or Gi/o, where Gs acts as a
stimulator of adenylate cyclase and the Gα subunit of Gi/o
acts as an inhibitor of PKA (Figure 1). PKA phosphorylates
Ca2+-channels, thereby enhancing the inﬂux of Ca2+ and
this increases the release of neurotransmitters [52]. Also
PKA phosphorylates SNAP-25 and this leads to a larger pool
of readily releasable vesicles [52]. The cAMP-system appears
to enhance the release of neurotransmitter in response to a
stimulus (Figure 2).
In vitro and in vivo exposure to lead acetate decreased
cAMP-dependent synaptic vesicle protein phosphorylation
in rat brain which is most likely a contributing mechanism
of lead toxicity [53].
Gs. Rodrigues and colleagues determined the eﬀect of
lead acetate on rat cerebral cortex membranes using 5 
Guanylylimidodiphosphate (Gpp(NH)p). Gpp(NH)p is a
nucleotide phosphorylase-resistant GTP analogue, which
is known to stimulate adenylate cyclase by saturating Gs.
On preincubation of membranes with lead acetate, the
stimulatory eﬀect of Gpp(NH)p on the adenylate cyclase
activity was inhibited [10].
Adenylate Cyclase. The same group [10] also determined
the eﬀects of lead acetate on adenylate cyclase activity in
the cerebral cortex membranes and found that lead caused
a concentration-dependent inhibition of adenylate cyclase
activity with an IC50 of 2.5 ± 0.1μM( Table 2)[ 10].
In another series of experiments, Ewers and Erbe [54]
determined the eﬀects of lead, cadmium, and mercury on
adenylate cyclase of the cerebrum, cerebellum, and the brain
stem,invitroandinvivo.Adenylatecyclaseactivitywasdeter-
mined in terms of the number of moles of cAMP formed.
Concentrationsbetween0.1and30μMleadnitrate,cadmium
nitrate, or mercury nitrate inhibited adenylate cyclase activity
in vitro in homogenates of the cerebrum, brain stem, and the
cerebellum. In vivo studies were performed on rats, which
received lead acetate dissolved in sterile demineralized water,
cAMP formation was determined 1 hour, 4 hours, and 24
hours after treatment. In the cerebellum, and brainstem,
adenylate cyclase activity increased after one hour by about
25% but was unaﬀected in the cerebrum. After four hours,
adenylate cyclase declined by 29%, 33%, and 21% in the
cerebrum, cerebellum, and brainstem respectfully. By 24
hours adenylate cyclase activity had returned to normal in
the cerebrum and brainstem but not in the cerebellum [54].
These diﬀerences in the eﬀects of lead acetate on adenylate
cyclase in diﬀerent parts of the brain may be an indicator of
the varied eﬀects of lead on diﬀerent isoforms of adenylate
cyclase.
Zinc (Zn2+) inhibited adenylate cyclase with an IC50
of 1-2μM and a Hill’s coeﬃc i e n to f1 . 3 3 ,w h i c hw a sn o t
competitive with Mg2+ or Mg2+ATPase [82]. Both the CI and
the CII domains of adenylate cyclase bind Zn2+ with high
aﬃnity which is correlated with Zn2+ inhibition of enzyme
activity [83].
2.2.2. The PLC System. The PLC system consists of GPCRs
coupled to Gq, which activate DAG and IP3 through PLC.8 Journal of Toxicology
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GPCR
Gs Gi/o
Adenylate cyclase Al CaM [Ca+2]
Cd, Hg, Pb, Zn
cAMP
PKA
CaMK
VGCC
Synapsin
synaptotagmin
Pb
Pb
Pb GPCR
SNAP25
synapsin
synaptotagmin
Figure 2:EﬀectsofMetalsonthecAMPSignalingPathwayatthePresynapticTerminal(green:activation/increase,red:inhibition/decrease).
GPCR’s are coupled to Gs or Gi/o, where Gs stimulates adenylate cyclase and Gi/o inhibits PKA. PKA phosphorylates Ca
2+-channels, thereby
enhancing the inﬂux of Ca
2+ and this increases the release of neurotransmitters. PKA phosphorylates SNAP-25 and this leads to a larger pool
of readily releasable vesicles. The cAMP-system appears to enhance the release of neurotransmitter in response to a stimulus. Metals act at
diﬀerent points in this pathway either enhancing certain processes or inhibiting some. A green color indicates an activation or an increase,
and a red color indicates an inhibition or a decrease.
IP3 causes an increase of intracellular calcium ([Ca2+]i)a n d
the activation of DOC2 and synaptotagmin which leads to
increased evoked release and readily releasable pool size.
DAG through PKC causes an activation of voltage-gated
calcium channels. PKC phosphorylates Munc 18, which neg-
ativelyregulatessyntaxin andsynapticvesiclefusion[52,84].
PKC activation eventually leads to an increase of spon-
taneous and evoked neurotransmitter release and more
readily releasable pool of vesicles (Figure 3)[ 52].
PKC. Metals that inhibit PKC include lead, aluminum, and
nickel. Pb2+ inhibits PKC enzymes through interactions with
its catalytic domains [85]. The eﬀect of aluminum on PKC is
debated: Julka and Gill demonstrated that aluminum lactate
given to male albino rats for four weeks, caused an inhibition
of PKC at all concentrations used (up to 100μM). This was
shown both in vivo and in vitro. The largest inhibition was
observed in the cerebral cortex (47.73%) followed by the
hippocampus (45.95%) and the corpus striatum (38.74%)
[20]. However, contrasting ﬁndings were determined by
Johnson and coworkers who showed that aluminum sulfate,
when given orally for a period of 4 months to male Sprague-
Dawley rats, showed an increase in PKC speciﬁc activity
by 60% and total activity by 70% in the soluble fraction
of cerebral cortex homogenates [69]. The diﬀerent eﬀects
of aluminum could be attributed to the mode of intake
reﬂectingdiﬀerencesinconcentrationofaluminumabsorbed
and its distribution to the brain or the duration of exposure.
Microarray analysis in neuronal PC12 cells indicated
that exposure to Nickel (Ni2+) caused a decline in the tran-
scription of two isoforms of PKC- prkcc, prkz, and two
regulatory binding proteins prkcbp1 and prkcdbp, and
also caused temporary upregulation and downregulation of
p r k c qa t2 4h o u r sa n d7 2h o u r s ,r e s p e c t i v e l y[ 86]. These
eﬀects are important in terms of the events at the synapse
because PKC activates voltage-activated calcium channels,
and increases the secretion of neurotransmitter through
eﬀects on proteins involved in neurotransmitter exocytosis-
Munc-18, and SNAP25 (a SNARE protein) [87].
IP3. Increase of [Ca2+]i in human cervix adenocarcinoma
cells by cisplatin (0.001–10μM) was dependent on extracel-
lular Ca2+ and was blocked by an IP3 receptor blocker. The
types 1–3 IP3 receptors were at the cellular membrane of
these cells, which suggests a possible mechanism of cisplatin-
induced calcium entry through IP3 receptor activation. This
was supported by the observation that the same results were
notobtainedinhumanosteosarcomacells,whichinaddition
did not show the presence of types 1–3 IP3 r e c e p t o r sa tc e l l
membrane [88]. Arsenic trioxide (As2O3) similarly caused
an increase in intracellular calcium which was dependent
on calcium release from the intracellular calcium stores
through the activation of IP3receptors [88]. MeHg also
causes an increase in intracellular calcium, which may be
due to release from intracellular stores through inositol
phosphate. MeHg doubled intracellular inositol phosphate
levels at concentrations above 3μM in vitro in rat cerebellar
granule neurons [89].
2.2.3. Intracellular Calcium ([Ca2+]i). Aluminum (Al3+)
caused an increase of [Ca2+]i in rat synaptosomes, which10 Journal of Toxicology
GPCR
Gq
PLC As, Pt, MeHg
DAG IP3
Al
Al, Ni, Pb
PKC Ca+2
Al, As, Pt, MeHg
VGCC DOC2
synaptotagmin
SNAP-25
Munc-18
Figure 3: Eﬀects of metals on the PLC signaling pathway at presynaptic terminal (green: activation/increase, red: inhibition/decrease).
The PLC system consists of GPCRs coupled to Gq, which activate PLC, which activates DAG and IP3.I P 3 increases intracellular calcium
([Ca
2+]i) and activates DOC2 and synaptotagmin which leads to increased evoked release and readily releasable pool size. DAG activates
PKC, which activates voltage-gated calcium channels. PKC phosphorylates Munc 18, which negatively regulates vesicle fusion and syntaxin.
PKC activation leads to the increased spontaneous and evoked neurotransmitter release. The eﬀects of metals on this pathway are shown in
this ﬁgure where a green color indicates an activation/upregulation and a red color indicates an inhibition/downregulation.
could be a consequence of the inhibition of the Ca2+-
ATPase [20]. 1μM arsenic trioxide (As2O3) caused an
irreversibleincreasein[Ca2+]i inhumanneuroblastomacells
(SY-5Y) and in human embryonic kidney 293 cells. This
rise of [Ca2+]i was independent of extracellular calcium,
but dependent on intracellular calcium stores. Blocking of
IP3 receptor and ryanodine receptors with their speciﬁc
blockers reduced the increase in [Ca2+]i indicating their
involvement in this process [88]. Cisplatin also increased
[Ca2+]i in a concentration-dependent manner in human
cervix adenocarcinoma cells but not in human osteosarcoma
cells. It is unlikely that the increase in [Ca2+]i is induced
by entry of extracellular calcium, but more likely through
activation of IP3 receptor as described above [88].
Inaddition,[Ca2+]i couldindirectlybeaﬀectedbyseveral
mechanisms. For example, [cis-(NH3)2Pt(H2O)2]2+,af o r m
of platinum, caused an uncoupling of oxidative phospho-
rylation one minute after exposure in a concentration-
dependent manner, which resulted in a release of Ca2+ from
the mitochondria. Cisplatin did not produce the same eﬀect
even at a concentration of 500μM[ 90]. However, another
study by Gemba et al. showed that mitochondrial uptake of
Ca2+ in rat kidney cortical mitochondria was decreased 24
hours after exposure to 500μM cisplatin [91].
Methyl-mercury (MeHg)0 . 5 – 1 μM caused an increase
in [Ca2+]i in vitro in rat cerebellar granule neurons, which
decreased cell viability (Table 4). This increase in cell death
was prevented 3.5 hours after exposure by using two
calcium channel blockers (ω-conotoxin and nifedipine)
and a calcium chelator (1,2-bis(2-aminophenoxy) ethane-
N,N,N9,N9-tetracetic acid tetrakis (acetoxymethyl) ester
(BAPTA)). The eﬀect of the calcium channel blockers could
indicate that they inhibit the MeHg interaction with the
target site or block of the entry of MeHg in addition to
the eﬀects on [Ca2+]i. BAPTA may have reduced calcium-
induced cell death at 3.5 hours after exposure but was unable
to prevent methylmercury-induced cell death at 24.5 hours.
That may indicate that calcium-independent pathways of
cell death are involved [92]. The increase of [Ca2+]i by
methylmercury is caused by release from intracellular stores
and through an inﬂux of Ca2+ into the cell [89].
In HeLa cells, trimethyl-tin caused spikes in [Ca2+]i as
well as sustained increases. The spikes were of variable
size and duration and required 0.25μM trimethyl tin.T h e
sustained increase in intracellular calcium was partially
reversible and dependent on the concentration of trimethyl
tin used, where a 5μM concentration caused an 8% increase
in [Ca2+]i. These eﬀects were independent of external
calcium concentrations; however, the increase in [Ca2+]i was
reduced when the internal calcium stores were compromised
[7].
Overall, any of the metals aﬀecting any channel or active
transport mechanism that involves calcium, at the cellular
membrane or the internal stores (as described above) could
potentially change [Ca2+]i.
2.2.4. Calmodulin (CaM). Calmodulin is a calcium binding
protein. Ca2+/calmodulin activates CaMK, which phospho-
rylates synapsin I and opens voltage-activated calcium chan-
nels by phosphorylation. Thereby Ca2+-inﬂux is increasing
which is crucial for releasing the neurotransmitter from
vesicles [52, 93].Journal of Toxicology 11
Aluminum (Al3+) decreased the biological activity of
CaM both in vitro and in vivo where inhibition in vivo
is largest in the hippocampus (36.56%), followed by the
cerebral cortex (31.76%) and the corpus striatum (22.49%)
[20]. Lead, however, had an opposite eﬀect as lead acetate
enhanced CaM activity both in vitro and in vivo resulting
in an increase in CaM-dependent synaptic vesicle protein
phosphorylation including the phosphorylation of proteins
such as synapsin I. This was proposed as a mechanism
for increased spontaneous release of neurotransmitter and
depletion of neurotransmitters norepinephrine and acetyl-
choline following exposure to lead [53].
2.3. Transporters
2.3.1. Ca2+-ATPase. Ca2+-ATPase activity in male albino rat
synaptic plasma membranes was reversibly inhibited by Al3+
(upto100μM).Thisinhibitionwasconcentrationdependent
with an IC50 of 10μM and resulted in an increase of [Ca2+]i
[20]( Table 3).
2.3.2. Na+/K+-ATPase. Cisplatin caused a concentration and
time-dependent decrease in Na+-K+ATPase activity in liver
and kidney cells [90]. Lead also aﬀected Na+-K+ATPase
activity, and one study showed lowered RBC membrane
Na+/K+-ATPase activity below 60% in 77% of patients with
Pb-Rbc ≥ 40μg/100mL while only 40% had the same
decrease in activity who had a Pb-Rbc ≤ 40μg/100mL [94].
Mercury compounds,c a d m i u m ,t r i e t h y l t i n ,a n dt r i m e t h y l -
tin also inhibit Na+-K+ATPase activity [95–97]. Triethyl lead
altered the microviscosity of the plasma membrane of ascites
tumor cell and also completely inhibited Na+-K+-ATPase at
concentrations 5–20μM possibly through direct interaction
with its catalytic subunit [98].
2.3.3. Mitochondrial ATPase. Mitochondrial ATPase was
inhibited in adult rat brain homogenates with an IC50 of
260μMb ytriethyltin [99]. Trimethyl tin has also been shown
to aﬀect mitochondrial ATPases in vitro [97].
2.4. Synaptic Vesicle Associated Proteins
2.4.1. Synaptotagmin I. Synaptotagmin I is a membrane
protein, which is hypothesized to be a Ca2+-sensor in
Ca2+-dependent neurotransmitter exocytosis. It has a short
intravesicular N-terminus and the cytoplasmic part is com-
posed mostly of two C2 domains, C2A and C2B. The C2A
domain is known to bind two Ca2+-ions and the binding
aﬃnity shows a correlation with the Ca2+ dependence of
exocytosis [100]. Synaptotagmin I binds phospholipids and
syntaxin in a Ca2+-dependent manner. The binding to
syntaxin is associated with exocytosis. The C2B domain of
synaptotagminIalsohasCa2+ bindingsitesandisinvolvedin
the Ca2+ dependent self-association of synaptotagmin I into
multimers [100].
Synaptotagmin I was recently described as a target site
for lead. Bouton and coworkers suggested a competitive
interaction between Pb2+ and Ca2+ for the Ca2+ binding
sites in the C2A domain of synaptotagmin I. At nanomolar
concentrations Pb2+ induced the binding of synaptotagmin I
to phospholipids with an EC50 of 8nM. This made it a thou-
sandtimesmorepotentthanCa2+ atincreasingphospholipid
binding to synaptotagmin I. Binding of Pb2+ also increased
the stability of the secondary structure of synaptotagmin I. A
concentration of 2μMf r e ePb2+ protected a 32kDa fragment
of synaptotagmin I from proteolytic degradation. It required
11μMf r e eC a 2+ to protect the same size of synaptotagmin
I. The same authors showed that Pb2+, unlike Ca2+, did
not induce the interaction of synaptotagmin I and syntaxin.
Overall, the interaction of Pb2+ was competitive with Ca2+
and nanomolar concentrations of Pb2+ could inhibit the
ability of micromolar concentrations of Ca2+ to induce the
interaction of synaptotagmin I and syntaxin [101].
Four binding sites of Cu2+ in the cytoplasmic C2A
domains of synaptotagmin I are discussed, three of which
are common to Ca2+, and one of which is unique to Cu2+.I t
was suggested that Cu2+ has a competitive interaction with
Ca2+,b u tCu2+ has a greater aﬃnity for the binding sites
common to these metals. Also it was determined that Cu2+
caused a conformational change in the protein, which may
make it less susceptible to trypsin cleavage [102]. Kathir and
colleagues looked at the interactions between Cu2+ and the
C2B domain of p40 synaptotagmin I, which is formed by
an alternative translation of the synaptotagmin I gene at
the Met103 of the p65 synaptotagmin I. They determined
that these interactions stabilized synaptotagmin I bound to
phosphatidyl serine vesicles [103].
2.4.2. Synapsin I and p38. Synaptic vesicle associated pro-
teins, synapsin I and p38, in rat CNS decreased on acute
exposure of rat to trimethyl tin. This decrease was both
concentration and time dependent; however, 12 weeks after
the exposure, the levels returned to normal. The decline was
not a result of loss of tissue which also occurs with trimethyl
tin exposure but was signiﬁcantly greater that the reduction
in tissue [104].
2.5. Neurotransmitters. Release of neurotransmitters is mod-
ulated by multiple mechanisms. How metals interfere
with some of these pathways has been described above.
T h ef o l l o w i n gp a r a g r a p hf o c u s e sh o wm e t a l sm o d u l a t e
neurotransmitter levels, their release, and uptake in the
presynaptic button.
2.5.1. Eﬀect on Neurotransmitter Metabolism. Treatment of
PC-12 dopaminergic neuronal cells with 10μg/mL copper
nanoparticles (Ø 90nm) caused a decrease in dopamine and
its metabolites 3.4-dihydroxyphenylacetic acid (DOPAC)
and homovanillic acid (HVA). This indicates that the
decrease in dopamine may be attributed to a decrease in
production and an increase in the breakdown of dopamine
[105].
In the same cell line, 10μg/mL manganese nanoparticles
(Ø 40nm) caused a suppression of the tyrosine hydroxylase
gene expression, which is involved in the synthesis of
dopamine [105]. Aluminum has been shown to decrease12 Journal of Toxicology
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striataldopaminecontentandinhibittheenzymedopamine-
β-hydroxylase, which converts dopamine to norepinephrine
[106].
Amongorganicmetals,trimethyltinhydroxidetreatment
of rats on alternate days from days 2–29 of life was
shown to decrease the amount of dopamine in the striatum
without aﬀecting dopamine metabolites homovanillic acid
and dihydroxyphenylacetic acid [107].
2.5.2. Eﬀect on Neurotransmitter Release. Stannous chloride
increased the amplitude of end-plate potentials in frog
neuromuscular junction. A concentration of 10–100μM
SnCl2 increased the quantum of end plate potentials (EPP).
However, the miniature end plate potential (MEPP) was
not aﬀected. Hattori and Maehashi (1988) suggested that
this was due to an increase in the evoked neurotransmitter
release while there was no eﬀect on spontaneous release
of neurotransmitter. Also, SnCl2 did not increase MEPP
amplitude or acetylcholine (Ach) potential, indicating that
the sensitivity to ACh was not altered [108].
Lead (Pb2+) in concentrations of at least 100nM was
found to increase the spontaneous release of glutamate and
GABA from the presynaptic terminal of rat hippocampal
neurons. This eﬀect was found to be concentration depen-
dent and partially reversible and the suggested mechanism
of action was through an intracellular signaling pathway
[109]. Similarly, it is likely that other metals also aﬀect
neurotransmitter release through their interaction with the
voltage-gated ion channels, intracellular signaling pathways,
and synaptic vesicle associated proteins.
One study looked at the eﬀects of cadmium on synaptic
transmission by perfusing the amygdala of rats with 10–
30μM CdCl2. There was an inhibitory eﬀect on the release
of excitatory neurotransmitters glutamate and aspartate
while the release of inhibitory neurotransmitters glycine
and GABA was stimulated [12]. Aluminum, as described in
previous chapters, aﬀects [Ca2+]i and, therefore, as expected,
inhibits the release and uptake of GABA from synaptosomes
by inhibiting Ca2+/calmodulin-dependent calcineurin. It
also inhibited pyruvate-supported calcium-evoked acetyl-
choline release in synaptosomes while in diﬀerentiated
SN56 cells it decreased acetylcholine release on short-term
exposure and increased release on long-term exposure [106].
2.5.3. Eﬀect on Neurotransmitter Reuptake. Trimethyl tin, in
vitro,inhibited the uptake of neurotransmitters GABA,nore-
pinephrine and serotonin, with an IC50 of 75, 43, and 24μM
in a concentration-dependent manner in mouse forebrain
synaptosomes. In vivo, at 2 and 14 hours after trimethyl
tin exposure, uptake of GABA, and serotonin was decreased
whereas there was no signiﬁcant decline in norepinephrine.
These changes in uptake of neurotransmitters could explain
theiralteredlevelsinthesynapticcleft[110].However,unlike
trimethyl tin, triethyl tin sulfate had no eﬀect on the levels of
dopamine, GABA or acetylcholine in rat brain on exposure
for 6 days a week from days 2 to 29 of life in mice [107].
Triethyl lead caused a concentration-dependent inhibi-
tion of Na+-dependent high-aﬃnity GABA uptake with an
IC50 of 10μM in rat brain synaptosomes. These results were
not dependent on Na+ and GABA concentration-indicating
that competition with Na+ and GABA were not the mecha-
nismofaction.Triethylleadalsocausedatime-andchloride-
dependent decrease in ATP [111]. Skilleter showed that
trialkyl lead at 1μM causes a decrease in pyruvate uptake by
mitochondria in a KCl medium which could possible explain
the decline in ATP [112]. However, since the inhibition of
GABA uptake occurs before a signiﬁcant decline in ATP,
Seidman and Verity suggested that the inhibition could be
due to a defect in GABA binding to uptake site [111].
2.6. Neuroﬁlaments and Microtubules. In vivo exposure of
Wistar rats to arsenic caused a dose-dependent decrease
in neuroﬁlament M and L proteins in the sciatic nerve
[113]. These components are required for the formation
of a heteropolymer in the cytoskeleton. Since the mRNA
expression of these proteins was unaﬀected, it is possible
that the decrease was a consequence of proteolysis. Caplain,
which is a calcium-activated cytoplasmic protease, has been
implicated in this phenomenon due to the increase in cy-
toplasmic calcium caused by trivalent arsenic [8].
Triethyl lead also aﬀects microtubules [114–116]a n d
neuroﬁlaments [117]. 50μM triethyl lead caused an inhibi-
tion of assembly and a disassembly of microtubules in vitro
in porcine brain [114]. Triethyl lead also caused a reversible
perinuclear coil formation of neuroﬁlaments in vivo in
mouse neuroblastoma cells, which was not associated with a
signiﬁcant change in the microtubules. In vitro, triethyl lead
caused bulging and constriction of isolated neuroﬁlaments
from porcine spinal cord, and an unraveling of ﬁbers in
preformed ﬁlaments [117].
2.7. Summary of Presynaptic Eﬀects of Metals. To summa-
rize, presynaptically, voltage-gated sodium, potassium and
calcium ion channels are aﬀected by metals such as Al3+,
Cd2+Pb2+,H g 2+, cisplatin, Sn2+,Z n 2+,C o 2+,N i 2+,M n 2+,
Ca2+,M g 2+,S r 2+, Ba2+, and La3+. Mechanisms of eﬀect
included binding to a speciﬁc target, charge screening, shift
of current-voltage curves, and competitive inhibition with
the physiological ion or a combination of mechanisms
[6, 11, 17, 19, 20, 23–32, 34, 41, 42, 44, 46–50]. Metals
also interact with intercellular signaling pathways to mod-
ulate synaptic transmission. Lead modulated Gs, adenylate
cyclase, PKC, and CaM [10, 53, 54, 85]. Adenylate cyclase
activity was also modulated by cadmium, mercury, and zinc
[54, 82, 83] while PKC was inhibited by lead, aluminum,
and nickel, [20, 69, 85, 86], and IP3 was inhibited by
cisplatin and arsenic [88]. Intracellular calcium was aﬀected
through interference with several targets including voltage-
gated calcium channels, Ca2+ ATPases, and intracellular
pathways. Al3+,A s 2O3, and cisplatin modulated intracellular
calcium [20, 88, 90, 91], and aluminum, and lead aﬀected
Calmodulin activity [20, 53]. Ca2+-ATPase activity was
inhibited by aluminum and Na+/K+-ATPase activity was
modulated by lead, cisplatin, mercury, and cadmium [20,
90, 94–96]. Synaptotagmin I, a synaptic vesicle associated
protein, was a target site for interaction with Pb2+ and Cu2+Journal of Toxicology 15
Figure 4: Postsynaptic ligand-gated ion channels as targets of neurotoxic metals. The main postsynaptic channels are the AMPA/kainate
and NMDA receptors whereas the main inhibitory receptors are the GABAARs. Each receptor represents a target for multiple metals. The
NMDARhas manymodulatorysitesidentiﬁed as itis moreextensively studied.NMDARis composed of aheteromer made ofNR1and NR2,
each having multiple subtypes. In the diagram blue arm represents NR1 while the red arm represents NR2, the main modulatory subunit.
Most metals have been shown to have eﬀects on NR2 subunit (for values regarding the speciﬁc subtypes refer to Section 3.1 and Table 5).
[101–103]. Neurotransmitter release was possibly aﬀected
through interaction with many of the targets above as well
as through interaction with synthesis and degradation of
neurotransmitters and enzymes in the metabolic pathway,
which resulted in modulation of neurotransmitter release by
metals such as copper, manganese, and tin [101–103]. The
mRNA expression of neuroﬁlaments was aﬀected by arsenic
[113]. Often contradictory results were obtained regarding
the eﬀects of metals, which may indicate that metals had
diﬀerent eﬀects on targets depending on the state of the
metal, its concentration, the medium, the area of the brain,
and whether the experiment was in vivo or in vitro.
3.PostsynapticTargets
The activation of ligand-gated receptor channels is vital for
controlling nerve cell inhibition or excitation and, therefore,
fashioning the response of individual neurons, neuronal
networks, and, ultimately, the entire brain. Consequently the
resulting currents through the associated channels will either
depolarize or hyperpolarize the postsynaptic terminal under
diﬀerent physiological conditions. The major excitatory
neurotransmitter in the brain is L-glutamate. There are three
classes of ionotropic glutamate receptors named according
to their potent excitatory amino acids: α-amino-3-hydroxy-
5-methyl-4-isoxazolepropionic acid (AMPA), kainate, and
N-methyl-D-aspartate (NMDA). The AMPA and kainite-
activated channels are designated non-NMDA receptor-
channels and will be further discussed in Section 3.2 while
metal actions at the NMDA/receptor channel complex are
analyzed in the upcoming Section 3.1.
The most abundant inhibitory neurotransmitter in the
brain is γ-aminobutyric acid (GABA), which acts on its
own class of ligand-gated channels. However, these receptors16 Journal of Toxicology
are subject to modulation by other compounds and ions,
includingmetals[118](Figure 4).Asmentionedintheintro-
duction, biological systems utilize metals because of their
catalytic versatility, but the high aﬃnity of these metals to
speciﬁc binding sites could possibly severely impair synaptic
transmissionand,therefore,causeamalfunctionofneuronal
networks which might result in changes in perception,
learning and memory, and ﬁnally change behavior, even at
very low and environmentally relevant concentrations.
3.1. The NMDA-Receptor/Channel-Complex. The N-methyl-
D-aspartate receptor (NMDAR) is a subtype of glutamate
ionotropic receptors. The most widely distributed and
studied NMDARs are tetrameric assemblies composed of
two NR1 subunits and two of the four diﬀerent NR2 types
(named A, B, C, and D), of which NR2A and NR2B are most
common [119, 120]. The physiological and pharmacological
properties of these receptors are dependent on the NR2
subunit, although diﬀerent NR1 splice variants may also
inﬂuence channel performance [121, 122]. NMDAR sub-
units have a characteristic modular architecture consisting
of two extracellular domains, the regulatory amino terminal
domain (ATD) and the agonist-binding domain (ABD), and
three membrane-spanning segments (M1, M3, and M4) and
a reentrant hairpin-like pore loop, M2 [123].
The associated NMDAR channel requires simultaneous
binding of two agonists, glutamate (Glu) and glycine (Gly),
for opening (for review, [124]). Gly has its binding site in
the ABD region of NR1 whereas NR2 ABD binds Glu [120].
The receptor-channel complex has unique properties such
as a high Ca2+ permeability. Also, the functional activation
of NMDAR channels is linked to a voltage-dependent
magnesium- (Mg-) mediated block [125, 126]. Extracellular
Mg2+ inhibits NMDA responses at membrane potentials
close to the resting membrane potential [127]. Studies of
the site of action of Mg2+ reveal that the N and N+1 site on
NR2 subunit are important for the Mg2+ block [128]. When
the membrane potential is suﬃciently depolarized, Mg2+
leaves its binding site and even potentiates NMDA responses
in low glycine concentrations. This potentiation is shown
to be due to increased NMDAR aﬃnity to glycine, in all
neurons [129]. However, there was also glycine-independent
potentiating eﬀect of Mg2+, which appeared to be largely
voltage-independent and subunit speciﬁc, being seen only
with NR2B-containing receptors. This potentiation has an
EC50 of ∼2mM[130].
All of these eﬀects reveal the complicated modulation
by Mg2+ on NMDAR currents. Some data suggest that
Mg2+ and spermine may completely or partially share a
common binding site; similar observations are obtained
using spermine [130, 131]. Three diﬀerent steps in the action
of these two substances could be distinguished: (1) increase
in glycine aﬃnity, seen in all neurons; (2) voltage-dependent
block, also seen in all neurons; and (3) glycine-independent
potentiation that was subunit speciﬁc [132, 133].
NMDARs contain a number of distinct recognition
sites for other endogenous and exogenous ligands, which
modulate their functions, such as divalent metal cations, as
explored in the later sections (Figure 4).
Zinc is the second most prevalent trace element in the
body. Most of the zinc ions (Zn2+) are trapped within
proteins, but some of it is loosely bound (chelatable zinc)
[134]. In the mammalian brain, chelatable zinc is distributed
mainly in the forebrain and localized almost exclusively
within synaptic vesicles of a subset of glutamatergic axon
terminals [135]. Since it is accumulated in synaptic vesicles,
it has been assumed that zinc is released, with glutamate,
duringneuronalactivity.Manystudieshaveshowedevidence
ofquantalcoreleaseofzinc andglutamate(forreview,[134]).
NMDARs are the best characterized synaptic zinc targets.
At low micromolar concentrations, Zn2+ selectively inhibited
NMDAR-mediated responses. The major eﬀect was through
voltage-independent, noncompetitive inhibition seen as a
decrease in the opening probability of the channel [136–
138]. However, at concentrations higher than 20μM, Zn2+
could also produce voltage-dependent inhibition, probably
by binding inside the pore at the Mg2+ blocking site [139].
It had been proposed that zinc is an endogenous ligand
controlling NMDARs functions [140].
An important consideration in NMDAR function and
pharmacology is that the Zn2+ binding to NR2A and NR2B
subunits is associated with discrete subunit selectivity [141].
NMDARs containing the NR2A subunit had a very high
sensitivity to extracellular Zn2+ (IC50 ∼15nM) [133, 142];
however, this inhibition never exceeded 60–80% [142]. The
mechanisms of this inhibition occurred in diﬀerent steps
[143]: in the ﬁrst step Zn2+ bound in the interlobe cleft of
the NR2A-NTD promoting its closure, which would exert
tension on the linkers connecting NTDs to ABDs. This eﬀect
would secondarily cause a disruption of the ABD dimer
interface. In turn, this disruption relieved the strain on
the transmembrane segments, and with proton binding, it
allows the closure of the channel gate [133]. This mechanism
of enhancement of proton inhibition was supported by
subsequent work [144].
Zinc hasamuchloweraﬃnitytotheNR2Bsubunit,com-
paredtoNR2A,withvoltage-independentinhibition(IC50 ∼
1μM) [122, 145]. It was suggested that the mechanism of
inhibition might be similar to the mechanism described for
NR2A receptors. However, zinc inhibition of NR2B receptors
appeared to not be dependent on pH [122], suggesting that
this inhibition might occur through a diﬀerent mechanism
[133]. Studies showed that Zn2+ bound with high aﬃnity to
as i t ei nN R 2 AA T Dr e g i o n[ 146] and with a lower aﬃnity to
a site in the same region of the NR2B [145]. The aﬃnities of
NR2CandNR2DtoZn2+ describedtobeevenhigher(IC50 >
10μM) [134].
Lead (Pb2+) is an exogenous heavy metal, which has been
a public health concern due to its widespread contamination
and its multiple toxic eﬀects. Eﬀects of acute exposure to
Pb2+ in the micromolar range were originally described
in cultured and acutely dissociated neurons as a reversible
inhibition of the NMDAR current [19, 147–150]. These
studies outlined several features of the eﬀects of Pb2+ (for
details, see review [151]). First, the inhibition was speciﬁc
for NMDA channels, which were signiﬁcantly more sensitiveJournal of Toxicology 17
Table 5: Eﬀects of metals on postsynaptic ligand-gated ion channels (↑—activation/upregulation, ↓—inhibition/downregulation).
Target NMDA AMPA/kainate GABA-A
Lead
Eﬀect
(1) ↓ open channel
probability (1) ↓ (35%)
(2) 60% ↓ in current
(reversible)
(3) >80% block
(4) ↓
(5) ↓
(6) ↓ receptor binding
(7) ↓
Conc
(1) 1–10 (1) 1mM
(2) 50
(3) 100
(4) IC50 = 1.52–8.19
(5) IC50 = 8.78 (in 0
Zn); IC50 = 1.26 (10
Zn) at high site, 94 at
low site
(6) IC50 = 300 (adult);
60 (neonatal)
(7) IC50 (free) = 0.55
Ref
(1) [16]( 1 ) [ 10]
(2-3) [14]
(4) [20]
(5) [9]
(6) [12]
(7) [5]
Zinc
Eﬀect
(1) ↓ open (1) ↑ (1) ↓
channel probability
(2) Channel block (2) ↓
↓ current in voltage
independent,
noncompetitive
manner
(3) NR2A block (3) ↑
(4) NR2B block (4) ↓
(5) ↓
(5) ↑ (16% to kainate,
15% to glu peak and
steady state)
(6) ↓ receptor binding
(76%) (6) ↓
(7) ↓ (7) ↑ AMPA response
(8) ↓ (8) ↑ desensitized
Kainate responses18 Journal of Toxicology
Table 5: Continued.
Target NMDA AMPA/kainate GABA-A
(9) ↓ AMPA and
kainate responses
Conc
(1) 1–10μM (1) 50 (1) 100 (dose
dependent)
(2) >20 (2) 1mM (2) IC50 = 19
(3) nM (3) <300
(4) μM( 4 ) >500
(5) High aﬃnity: IC50
= 0.77; low aﬃnity:
IC50 = 153
(5) 10
(6) 1mM (6) IC50 = 700
(7) IC50 (free) = 1.3 (7) EC50 = 30
(8) IC50 = 42.9 (8) EC50 = 13
(9) IC50 = 1.2-1.3mM
(1-2) [11] (1-2) [17]( 1 ) [ 13]
Ref
(3) [17, 21] (3-4) [7, 25]( 2 ) [ 10]
(4) [17] (5-6) [15]
(5) [9] (7-9) [22]
(6) [12]
(7) [5]
(8) [22]
Magnesium
Eﬀect
(1) ↑ NMDA-R
aﬃnity to glycine in
all receptors
(1) ↓ (27%)
(2) ↓ elementary
c u r r e n ta t+ v e
potentials(+20 to
+80)
(3) ↑ glycine and
voltage-independent
and subunit speciﬁc
(4) external channel
block, voltage
dependent
Conc
(1) 10mM (1) 20 mM
(2) 10mM
(3) 2mM
(4) IC50 (−100mV) =
2–15
Ref (1–3) [6]( 1 ) [ 15]
(4) [2]Journal of Toxicology 19
Table 5: Continued.
Target NMDA AMPA/kainate GABA-A
Manganese
Eﬀect
(1) ↓ (activity
dependent, channel
blocker)
(1) ↓ (46%) (1) Little or no eﬀect
Conc
(1) Ki = 35.9
(presence of glu and
gly); Ki = 157 (no glu
nor gly)
(1)25mM (1)1mM
Ref (1) [8]( 1 ) [ 15]( 1 ) [ 10]
Copper
Eﬀect
(1) ↓ (1) ↓ (1) ↓ (voltage
independent)
(2) ↓ receptor binding
(54%)
(2) ↓ kainite-induced
current
(3) ↓ (channel block) (3) ↓ eﬃcacy of
kainate
(4) ↓
(5) ↓ voltage
independent,
noncompetitive
Conc
(1) ND (1)
(2) 1mM (2) IC50 = 4.3
(3) Ki = 195 (no
coagonists); (3) 30
two sites (9.4, 248)
with glu and gly (1) IC50 = 5
(4) IC50 = 15
(5) IC50 (free) = 0.27
Ref
(1) [17, 23]( 1 ) [ 17]( 1 ) [ 10]
(2) [12] (2-3) [30]
(3) [8]
(4) [30]
(5) [28]
Cobalt
Eﬀect (1) ↓ (1) ↓ (1) ↓
(2) ↓ (2) ↓ (29%)
Conc (1) 2mM (1) 2mM (1) 2mM
(2) IC50 = 6.1 mM (2) 1mM
Ref (1) [3]( 1 ) [ 3]( 1 ) [ 3]
(2) [15]( 2 ) [ 10]20 Journal of Toxicology
Table 5: Continued.
Target NMDA AMPA/kainate GABA-A
Nickel
Eﬀect
(1) NR2A: ↓,N R 2 B :↑ (1) ↓ (kainite-induced
current) (1) ↓(20%)
(2) NR2A ↓ (100% at
+ve potentials)
(2) ↓ (glu-induced
current)
(3) NR2B ↓
(4) NR2B ↑ (voltage
independent)
Conc
(1) 30
(2) IC50 = 36 at
−60mV and 81 at
+40mV
(3) IC50 138 at
−60mV and 442 at
+40mV
(4) 3
(1) IC50 = 420 (1) 1mM
(2) IC50 = 2.6mM
Ref (1) [16] (1-2) [15]( 1 ) [ 10]
(2–4) [21]
Mercuric chloride
Eﬀect (1) ↑ 130%
(2) ↑ (270%)
Conc (1) 1
(2) 100
Ref (1) [1]
(2) [19]
Methyl mercury
Eﬀect (1) ↓ receptor binding (1) ↓ amplitude to
82.4%
Conc (1) IC50 = 0.95
(neonatal); 70 (adult) (1) 100
Ref (1) [12]( 1 ) [ 55]
Cadmium
Eﬀect
(1) ↓ receptor binding
(58%)
(1) ↑ (kainate to
108% and QA to
115%)
(1) ↓ (18%)
(2) ↓ (39% of control) (2) ↓ (kainate to 79%
and QA to 60%)
(3) ↓ ( 4 %o fc o n t r o l )
Conc
(1) 1mM (1) 50 (1) 1mM
(2) 50 (2) 1mMJournal of Toxicology 21
Table 5: Continued.
Target NMDA AMPA/kainate GABA-A
(3) 1mM
(1) [12] (1-2) [18]( 1 ) [ 10]
Ref (2-3) [18]
Lanthanide
Eﬀect
(1) ↓ NMDA response
in a
voltage-independent
manner
(1) ↑
(1) ↑ (300% max) and
↑ as the potential
more −ve
(2) ↓
Conc (1) ) IC50 = 2 (1) 1–100 (1) EC50 = 231
(2) >100
Ref (1) [27] (1-2) [27]( 1 ) [ 10]
Trimethyl-tin
(TMT)
Eﬀect (1) ↓ (35%) reversible (1) ↓ (20%)
irreversible
(1) ↓ (30%)
irreversible
Conc (1) 100 (1) 100 (1) 100
Ref (1) [4]( 1 ) [ 4]( 1 ) [ 4]
to Pb2+ inhibition than other glutamate channels. Secondly,
the channel block was independent of voltage [148–150],
and therefore the interaction site was likely to be located
away from the electric ﬁeld, or outside the conducting
pore. Thirdly, the eﬀect was noncompetitive since increasing
the glutamate or glycine concentration could not overcome
the block of the current [148, 152]. Biochemical studies
suggested that the inhibitory eﬀects of Pb2+ on NMDA
receptorswereage-andbrain-regionspeciﬁc[152–154].One
important observation in Pb2+ neurotoxicity was that the
hippocampus appears to be more sensitive than other brain
regions [153, 155, 156].
The eﬀect of Pb2+ on glutamate and NMDA-evoked cur-
rents depended on the subunit composition of the receptor-
channel complex. Concentration-dependent Pb2+ inhibited
the currents activated by either Glu or NMDA in oocytes
expressing NR1-2A or NR1-2B (Table 1,[ 157]). Yamada and
colleagues [158], however, showed that higher concentra-
tions were needed than mentioned before, although, there
were methodological diﬀerences between the two studies,
which could account for the diﬀerent results (for details,
[157]).
Also, Pb2+ at low concentrations (<1μM) acted as a
positive modulator of agonist action on NR1-2AB and NR1-
2ACreceptorswhereasathigherconcentrationleadinhibited
NR1-2AB and NR1-2AC receptors, but with less potency
compared to NR1-2A or NR1-2B [157, 159].
There is incongruity whether lead acts via the zinc
binding site or through a diﬀerent site. A set of experiments
demonstrated that in the presence of increasing amounts of
Pb2+, there was a concentration-dependent downward shift
of the Zn2+ inhibition curve; also, the values of IC50 for
Zn2+ inhibition decreased as a function of increasing Pb2+
concentrations. The eﬀects of Zn2+ on Pb2+ curve and IC50
were analogous [160]. These ﬁndings suggested that the two
metalsactviaindependentbindingsites,whichisinlinewith
the observation that increasing concentrations of Pb2+ did
not aﬀect the Zn2+ IC50 [154]. However, these results were
in contrast with other ﬁndings which report that the two
cations compete for the same binding site [161, 162].
Nickel (Ni2+) is a trace element, which is essential for
many biological organisms, but could also induce toxicity.
TheeﬀectsofNi2+ onNMDAchannelactivityweredescribed
as a voltage-dependent and “Mg2+-like” inhibition [127].
Later work showed a potentiation of homomeric NR1a
channels [121] and an inhibition of NR1-2A channels
[13, 146]. In more recent studies, it is suggested that,
besides the voltage-dependent Mg2+-like inhibition, Ni2+
causes a potentiation of NR2B-containing channels and
a voltage-independent inhibition (Zn2+-like inhibition) in
those neurons containing NR2A [163].
Nickel also caused a reduction of single channel current
amplitude at negative voltages while the dependence on
membrane voltage was slightly steeper for NR2A than
NR2B [13]. Several analogies with Mg2+-like inhibition
indicated that it might interact with either the N or N+1
site in the pore-forming region of the NR2 subunit [13].22 Journal of Toxicology
Support for the above theory came from an experiment
showing that a single mutation in the NR2B site at the
N+1 site would completely abolish the voltage-dependent
block Ni2+ [123]. The N+1 residue had been shown to be
a critical binding site for Mg2+ b l o c ki nN R 2 As u b u n i t[ 128].
Moreover, at positive potentials the eﬀects of Ni2+ were
highly subunit dependent. NR2A-containing channels were
blocked in a voltage-independent manner whereas NR2B
containing channels were facilitated [13] (see Abbreviation
section). However, at higher concentrations (IC50= 442μM),
avoltage-independentinhibitionwasalsopresentinNR1-2B
channels [123]. The voltage-independent inhibition site of
Zn2+ was investigated as a potential site for Ni2+ inhibition,
but this did not seem to be the case. Besides the diﬀerence
in blocking aﬃnity, Zn2+ inhibition was pH dependent
[122, 164] while Ni2+ inhibition was not [163]. Also,Z n 2+
inhibition was never more than 60–80% (as described in
section 3.2.1), while Ni2+ inhibition approached 100% at
positive potentials [123]. Other results also showed that
mutations that aﬀect the inhibition of Zn2+ did not modify
Ni2+ sensitivity [146].
The NR2B-selective potentiation was suggested to share
the site of action with spermine, as Ni2+ partially obscured
the eﬀect of spermine when they were applied concurrently
[123].
Although the actions of zinc, lead, and nickel on
NMDARs were intensively investigated, there are also some
reports that other metals have an eﬀect on these receptors
and channel activity.
Copper (Cu2+) is an endogenous metal in the human
brain[165],anditisanestablishedfactthatcopper represents
an integral part of neurotransmission [166]. It is released
from synaptic vesicles following neuronal depolarization
[167]. The concentration of copper in the synaptic cleft
could reach up to 100μM[ 168]; later studies estimated the
concentration of copper released into the synaptic cleft to be
intherangeof ∼15μM[169,170].However,thetopographic
distribution showed marked variations between diﬀerent
brain areas [171]; the highest concentration of copper has
been found to be in the hypothalamus [172].
Cu2+ acts on NMDA receptors and reduces the current—
induced by 50 μM NMDA—in a concentration-dependent
manner with an IC50 of 15.9μM. This block was completely
and quickly reversible, even in the absence of antioxidant
dithiotreitol, suggesting that the inhibition was not an
oxidizingeﬀect[173].FurtherstudiesshowedthatCu2+ inhi-
bition was characterized by voltage-independent, but use-
dependent mechanism of action, as the degree of inhibition
was dramatically decreased in the absence of agonists [174].
Another trace metal required for normal brain function
is manganese (Mn2+). In the human brain,M n 2+ is most
concentrated in the globus pallidus, caudate, and putamen,
but also found in other areas [175]. Mn2+ produces a strong
voltage-dependent block in response to NMDA [176]. It
was, also, a competitive antagonist of MK-801 binding to
the NMDAR-channel. Its inhibitory eﬀects were activity-
dependent since Mn2+ was a more potent inhibitor in the
presence of NMDA coagonists (Glu and Gly) than in their
absence [177]. Taking these studies together, they indicate
that Mn2+ is an NMDAR channel blocker. Interestingly, the
inhibitory constant for Mn2+, in the absence of Glu and
Gly, was signiﬁcantly diﬀerent in neuronal membranes from
the cerebellum relative to other brain regions; however, in
the presence of the agonists, Mn2+ was equally potent in
inhibiting NMDARs in diﬀerent brain regions [177].
3.1.1. The Glycine-Binding Site of the NMDA-Receptor/Chan-
nel Complex. The NMDAR glycine-binding site was sus-
ceptible to modulation by divalent cations, especially when
the glycine site was not saturated. Low, extracellular con-
centrations of Mg2+ potentiated NMDAR currents. The
potentiation was the result of an increase in the aﬃnity of
NMDAR for glycine [129, 130, 178]. The mean glycine EC50
valuewas100–133nMincontrolconditionsandwasreduced
to 60–62nM in the presence of 10μM Mg2+ [178]. This
increase in aﬃnity was also demonstrated by decreasing the
inhibitory potency of NMDAR glycine-site antagonists upon
the addition of potentiating concentrations of Mg2+[129,
178, 179]. Ca2+ had the same eﬀect as Mg2+ [129, 178, 179].
Concentrations of Pb2+ and Zn2+ higher than 10μM
inhibited NMDAR potentiation by Ca2+ and Mg2+ [178].
These ﬁndings were supported by other studies, which
showed that increasing concentrations of Ca2+ diminished
the inhibition of NMDAR currents by Zn2+ [136], or Pb2+
[180]. It is suggested that these divalent cations act on the
samesite,andCa2+ andMg2+ haveoppositeeﬀectsonglycine
binding compared to Pb2+ and Zn2+ [178].
Even the presence or absence of glycine modulated the
eﬀects of some of the cations: for example, Cu2+ and Mn2+
are both potent NMDAR channel inhibitors (as shown
above), but in the presence of glycine and glutamate, Cu2+
was more potent than Mn2+, and in the absence of glycine,
Mn2+ was slightly more potent [177].
3.2. AMPA and Kainate Receptors. The two classes of ion-
otropic glutamate receptor-channels, which are designated
non-NMDA channels, are AMPA (α-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid) and kainate receptors,
named after their most potent excitatory amino acids. The
AMPAR channel is also activated by kainate (for review,
[181]). Also, AMPARs mediate the fast excitatory synaptic
transmission in the CNS [182].
AMPA/kainate receptor-gated channels are permeable
to Na+ and K+ and more or less impermeable to Ca2+;
however, there is a subpopulation of central neurons,
which contain AMPA/kainate receptors with enhanced Ca2+-
permeability [183, 184]. This Ca2+ conductance triggered by
the AMPA/kainate receptors seemed to be dependent on the
absence of the GluR2 subunit [119, 182, 185].
Extracellular calcium ions produced rapid and reversible
voltage-independent inhibition of AMPARs, with both Ca2+
permeable and Ca2+ impermeable AMPAR being equally
sensitive [186]. The Ca2+ eﬀects were agonist dependent,
more prominent in the case of AMPA compared to Glu or
kainate.ThesedatasuggestedthatCa2+ enhancesdesensitiza-
tion, as two well-known antidesensitization agents prevented
Ca2+ inhibition through Ca2+ binding to a modulatory site
in the AMPAR [186].Journal of Toxicology 23
Eﬀects of zinc on AMPA/kainate receptors have also been
explored. Zn2+ appeared to have a dual eﬀect on AMPAR:
at micromolar concentrations, it enhances AMPA receptor
responses whereas at millimolar concentrations, it inhibits
them [136, 187]. These eﬀects of Zn2+ appear to be subunit
speciﬁc as well. Experiments using cloned AMPAR expressed
in oocytes demonstrate that, in normal calcium-containing
solution, zinc could potentiate current from homomeric
GluR3 receptors over a narrow range of 4–7.5μM Zn2+
while homomeric GluR1 receptors could not be potentiated,
but are inhibited by 10μM Zn2+ [188]. Additionally, in
calcium-free solution, the inhibition caused by Zn2+ on
GluR1 shifted to ≥1 mM and potentiation was attainable
reaching a maximum of ∼200% at 50μM Zn2+. Also, GluR3
showed maximum potentiation not signiﬁcantly diﬀerent
from GluR1 potentiation. The presence of GluR2 subunit
in heteromeric expression of GluR2/GluR3 prevented the
potentiation by Zn2+, but also allowed inhibition (with
500μM Zn2+, current was 39% of control). The presence
of GluR2 rendered the eﬀects of Zn2+ independent of Ca2+
levels (for details, [189]).
The eﬀects of other divalent metals eﬀects were explored
onthesechannelsbutlessextensivelycomparedtoNMDARs.
Various metals caused inhibition of Ca2+ impermeable
AMPAR with the following rank order of inhibition: Ni2+>
Zn2+> Co2+> Ca2+> Mn2+> Mg2+ (for values, refer to
Table 5)[ 190]. The proposed mechanism of action is that
complexes of divalent cations and AMPAR agonists compete
with the free agonists rather than the cations themselves.
This mechanism ﬁts the data in which a competitive type
of inhibition is observed; in addition, an increase in agonist
concentration reduce the inhibitory eﬀects of divalent metals
less than that of DNQX (the classical competitive AMPAR
antagonist) [190].
3.3. GABA Receptor. γ-Aminobutyric acid (GABA) is the
majorinhibitoryneurotransmitterinthemammaliancentral
nervous system. The synaptic transmission mediated by
GABAA receptor-channel complex leads to a hyperpolar-
ization of the cell membrane due to the fast activation
of postsynaptic chloride channels upon the exposure to
GABA [191]. The GABAAR is comprised of pentameric
combination of α1–6, β1–4, γ1–3, δ 1, and/or ε1 subunit
subtypes that form an intrinsic chloride ion channel, and
each subunit comprises four domains. GABAARs have some
recognized allosteric binding sites such as barbiturates,
benzodiazepines, and picrotoxin [192, 193]. The properties
of the allosteric binding sites were inﬂuenced by the subunit
subtype composition of GABAAR( f o rr e v i e w[ 194]).
3.3.1. Inhibitory Eﬀects of Metal Ions. The GABAARr e s p o n s e
to GABA-evoked currents was modulated by a number of
divalent metal cations. Zinc, cadmium, nickel, manganese,
cobalt, lead, and copper inhibited the response to GABA. The
inhibition by divalent metals has consistently been shown to
be reversible with no or little voltage dependence [14].
Zn2+ had the potential to directly interact with the
GABAAR to inﬂuence inhibitory postsynaptic currents
(IPSC) amplitudes and kinetics [118]. Zn2+ suppressed the
GABA-induced chloride current with a Kd of 19μMi na
noncompetitive, voltage-independent manner, and without
interference with any of the allosteric sites on the GABA-R
[195]. Using cultured hippocampal neurons, studies showed
that Zn2+ reduced the amplitude, slowed the rise time, and
accelerated the decay of mIPSCs. Evidence indicated that
inhibition of mIPSCs by Zn2+ was attributed to an allosteric
modulatory site located on the extracellular domain of
GABAA receptors[196,197].Inaccordancewiththeprevious
hypothesis, single-channel studies have also shown that Zn2+
reducedtheopeningfrequencywithnoevidenceofﬂickering
[198–200].
From another perspective, the eﬀects of Zn2+ were
subtype-speciﬁc. The zinc-sensitivity of the channels seemed
to be dependent on the absence of γ subunits, as its
presence in any combination with other subunits led to
the formation of GABAA receptors almost insensitive to
Zn2+ [201, 202]. Furthermore, the presence of a δ subunit
enhanced zinc sensitivity [202, 203]. The exchange of a
particular subunit with other members of the same subunit
family (α1v e r s u sα3, β1v e r s u sβ2, and γ1v e r s u sγ2) did not
alterthelargediﬀerenceinZn2+ sensitivitybetweenGABAAR
containing or lacking γ subunit [202]. Later studies showed
that recombinant GABAAR, which contain α4, α5, and α6
subunits, were more sensitive to zinc than those that contain
α1 subunits [204–207]. Given that the majority of synaptic
GABAAR are of the α-, β-, γ-isoform [208], together with the
abovestudies,indicatethatalikelytargetofZn2+ modulation
is an extrasynaptic α-, β-o rδ-receptor [118].
In rats dorsal root ganglion (DRG) neurons, Cu2+ at
concentration of 15μM, suppressed the peak amplitude
of the GABA-induced current to approximately 50%; the
blocking was exerted and reversed quickly, and it was
independent of membrane potential [195].
The similar blocking proﬁles of Cu2+ and Zn2+ led to
the question whether they shared a common binding site.
Competition experiments showed that Zn2+ suppression
of GABA-induced current was decreased with increasing
concentrations of Cu2+, suggesting that Zn2+ and Cu2+ act
on the same allosteric site to inhibit GABAAR[ 55].
In a later study, the copper-induced block of GABAARi n
Purkinje cells developed slowly, was poorly reversible, and
decreased with increasing GABA concentrations. The block
occurredatlowconcentrationsindicatingahighaﬃnitywith
an IC50 ∼35nM [209]. The copper block of GABAARi n
Purkinje cells seemed to have a higher aﬃnity compared to
the block in DRG [195] and olfactory bulb neurons [210].
Another diﬀerence between these tissues was that Cu2+ in
DRG cells interacts in a noncompetitive manner while in
Purkinje, Cu2+ decreased the potency of GABA without
aﬀecting the maximal response. A possible explanation for
this discrepancy might be diﬀerent subunit composition of
the GABAAR[ 210].
The eﬀects of multiple divalent metals (cadmium, nickel,
manganese, zinc, and barium) were shown in a study of
GABA responses of embryonic chick spinal cord neurons.
The results were suggestive of an allosteric mechanism
of inhibition of GABAAR currents. Through combination24 Journal of Toxicology
experiments they showed that the ions acted at a common
site but possessed diﬀerent intrinsic eﬃcacies with the
following rank: Zn > Cd> Ni> Mn. Ba was thought to bind
to the site but lacked eﬃcacy as an inhibitor of the GABA
response [14]. The rank of eﬃcacy was supported by other
experiments [195].
3.3.2. Excitatory Eﬀects of Metal Ions. Lanthanides comprise
aseriesof15metalsstartingwithlanthanum(La)andending
with lutetium. In sub-millimolar concentrations, lanthanum
ions modulate GABA-induced currents [55, 191, 211].
La3+ increased the aﬃnity of GABA for the receptor in
a concentration-dependent manner with an EC50 = 231μM
and maximum enhancement to about 300% of control
with 1mM. This potentiation was completely and quickly
reversed, but was more enhanced as the potential became
more negative (1.6% per 10mV) [195]. Also, this eﬀect
was independent of the presence or absence of barbiturates,
benzodiazepines, picrotoxin, or Zn2+/Cu2+, indicating that
it was bound to a site diﬀerent from all of the binding
sites of the above substances [55]. La3+ did not activate
transmembrane currents, it only potentiated GABA-induced
currents; also La3+ did not aﬀect the amplitude of the
maximum response induced by GABA. These data together
suggested that La3+ increased the aﬃnity of GABAARt o
its agonist [212]. Other lanthanides exhibited enhancing
actions, and the eﬃcacy increased with increasing the atomic
number, such that Lu3+ (1mM) increased the current to
1230% of control [55]. However, previously it was reported
thatlanthanidesgenerateinwardcurrentsontheirowninthe
absence of GABA [55]. This controversy might be due to use
of diﬀerent tissues; as La3+ did not activate transmembrane
currents in CA1 hippocampal pyramidal neurons whereas
La3+ generated inward currents in DRG neurons.
Additionally, recombinant GABAAR studies suggested
that changing the α-subunit subtype from α1t oα6 alters
the eﬀects of lanthanum from potentiation to inhibition at
comparableconcentrations.Thesestudiesalsosuggestedthat
the maximal inhibition of GABAARc u r r e n tb yLa3+ in α6-
containing receptors is greater in the presence of δ subunit
(83%) than in the presence of γ subunit (32%) [213].
Another cation that might aﬀect GABAARi smercury
(Hg). In its inorganic form, GABAAR channel complex was
strongly stimulated by low concentrations of Hg [214].
Mercuric chloride (100μM) increased the GABA-induced
current to 270% of control, and increased it to 115% of
control with 0.1μM[ 55] indicating its high potency.
3.4. Summary of Postsynaptic Eﬀects. The main postsynaptic
targets are the ligand-gated receptors including, but not
limited to, NMDA, AMPA/kainite, and GABA receptors. Of
those, NMDAR channels are the most widely studied recep-
tors due to their association with disease status. Relatively
fewer studies have been done on other targets, which could
lead to underestimation of their roles in metal toxicity.
Two main mechanisms established for metals eﬀects on
NMDAR: Mg2+-like inhibition, which is voltage dependent,
or Zn2+-like inhibition, which is voltage independent. Lead
and copper were found to inhibit NMDAR in Zn2+-like
pattern. However, copper-mediated inhibition of NMDAR
was use dependent which was also true for manganese-
mediated inhibition [160–162]. Nickel on the other hand,
showed an Mg2+-like inhibition at negative potentials. How-
ever, it had diﬀerent eﬀects on NR2B and NR2A containing
channels at positive potentials. It caused a potentiation of
NR2B-containing channels and a Zn2+-like inhibition in
those containing NR2A. However, at high concentrations,
NR2B-containing receptors also showed Zn2+-like inhibition
at positive potentials [163]. Another major target on the
NMDAR was glycine-binding site with multiple metals
aﬀecting it. Ca2+ and Mg2+ potentiated NMDAR currents
whereas Pb2+ and Zn2+ inhibited NMDAR currents. All of
these four divalent metals might act on the same binding site
with diﬀerent eﬀects [178]. Also, the presence or absence of
glycine aﬀected the potency of Cu2+ and Mn2+, such that in
the presence of Gly, Cu2+ was more potent, whereas in the
absence of Gly, Mn2+ was slightly more potent [177].
The main inhibitory receptors in the brain, GABAA,
are also modulated by a variety of metals. Certain metals
suppressed the GABA-induced chloride current while others
augmented it. Multiple divalent metals had inhibitory eﬀects
on GABA-induced current. Cu2+ and Zn2+ suppressed
GABAAR in an equipotent manner, and there was some
evidence that they act on the same site. Other divalent
metals also showed inhibitory eﬀects through an allosteric
mechanism of inhibition, and they demonstrated a common
site of action but with diﬀerent intrinsic eﬃcacies with the
rank Zn2+> Cd2+> Ni2+>Mn2+ [14].
Interestingly, Lanthanides exhibited enhancing eﬀects of
GABA-induced currents. The eﬀect was completely and
quickly reversible. The eﬃcacy increased with increasing
atomic number [55]. However, recombinant GABAARs t u d -
ies suggestedthatchanging the α-subunitsubtype couldalter
the eﬀects of lanthanum from potentiation to inhibition in a
comparable concentration range.
Mercury was another metal, which had inhibitory and
excitatory eﬀects. In its inorganic form, GABAAR channel
complex was strongly stimulated by low concentrations
of Hg.H o w e v e r ,methyl mercury was a potent inhibitor
of GABA-induced current, and this eﬀect was irreversible
[55]. This showed how organic metals might behave diﬀer-
ently compared to inorganic cations; however, there is less
information in the literature about the eﬀects of organic
metals. One of the most toxic organic metal is trimethyl-tin
(TMT). At a concentration of 100μM, around 20–30% of
AMPAR and GABAAR currents were inhibited whereas 35%
of NMDAR ion currents were blocked [215].
4. Disruptionof SynapticPlasticity
Multiple reports have demonstrated that human exposure to
environmentally concentrations of certain metals can result
in cognitive deﬁcits.
Arsenic consumption, mainly through contaminated
water, has been found to be associated with impairmentJournal of Toxicology 25
Figure 5: Proteins involved in the formation of long-term potentiation (LTP) and toxic eﬀects of metals. LTP consists of diﬀerent forms:
early-phase LTP (E-LTP), which lasts only a few hours, and late-phase LTP (L-LTP), which lasts for several days. E-LTP includes short-
term potentiation (STP), which is dependent on NMDA receptor activation and Ca2+/calmodulin and LTP-1 that involves protein kinase
C( P K C )a n dC a 2+/calmodulin-dependent protein kinase- (CaMK-) dependent phosphorylation. While STP can be formed by activation
of NMDA and calmodulin dependent enzymes, LTP-1 requires activation of PKC via DAG that is produced after the activation of mGluRs.
PKC and CaMKII then phosphorylate AMPA and NMDA receptors. L-LTP consists of the later phases of LTP, which are LTP-2 and LTP-3.
LTP-2 requires synthesis of new proteins and receptors whereas LTP3 requires gene transcription. Activation of adenylate cyclase and cAMP-
dependent activation of PKA are required for the formation of the later phases of LTP. LTP-3 depends on the activation of extracellular
signal- related kinase 1/2 (ERK1/2) and CaM kinase IV, which in turn phosphorylate CREB and lead to new protein synthesis. Other factors
such as p38 mitogen-activated protein kinase (p38 MAPK) leads to the formation of long-term depression (LTD). Several of the molecules
required to produce these diﬀerent forms of LTP have been identiﬁed and are targets for metal toxicity, which have been shown (red arrows
indicateinhibitionwhereas green arrowsindicateactivation bymetals.Blackarrowsindicateactivationthatoccurs duringnormalformation
of LTP).26 Journal of Toxicology
of long-term memory and a reduction in the verbal IQ of
children [216, 217]. Lead has been studied extensively for
its role in disruption of synaptic plasticity in an attempt to
explain the cognitive deﬁcits observed in children with ele-
vated blood lead levels. The CDC currently considers blood
Pb2+ level of 10μg/dL to be the threshold for impairment of
c o g n i t i v ef u n c t i o ni nc h i l d r e n[ 218], although recent studies
have observed that cognitive impairment can occur even at
blood lead levels <10μg/dL [219]. There have been reports
that aluminum also aﬀects synaptic plasticity, which has
been implicated in the pathogenesis of Alzheimer’s disease,
although this topic is highly debated. It has been argued
that these detrimental eﬀects on learning, memory, and
cognition, which are associated with exposure to metals, may
be linked to the disruption of processes that are involved in
synaptic plasticity. The formation of long-term potentiation
(LTP) is impaired in mice that have inborn low learning
capacity indicating the crucial role for synaptic plasticity as
the basis of learning and memory. Impairment of LTP has
beenobservedwithexposuretolead [220].Moreover,studies
haveshownthataluminumalsoimpairedhippocampallong-
term potentiation (LTP) and long-term depression (LTD) in
ratsbothinvivoandinvitro[221,222].Also,multiplemetals
have been shown to have diﬀerent concentrations in patients
with Parkinson’s disease compared to healthy individuals,
andthelevelsofaluminumhavebeenidentiﬁedasapotential
diagnostic marker [223].
To understand how metals and their compounds aﬀect
learning and memory, their eﬀects on diﬀerent stages of
LTP and LTD were compared to identify speciﬁc sites of
interaction for particular metals as well as targets common
to more than one metal.
Recently, it has been shown that LTP consists of diﬀerent
succeeding forms: early-phase LTP (E-LTP), which lasts only
a few hours, and late-phase LTP (L-LTP), which lasts for
several days [224–226]. Several of the molecules required to
produce these diﬀerent forms of LTP have been identiﬁed
and are targets for metal toxicity [224, 225, 227]( r e f e rt o
Figure 5 and Table 6).
Early-LTP. it includes short-term potentiation (STP),
which is dependent on NMDA receptor activation
Ca2+/calmodulin; and LTP-1 that involves protein kinase
C (PKC) and Ca2+/calmodulin-dependent protein kinase-
(CaMK-) dependent phosphorylation. While STP can be
formed by activation of NMDA and calmodulin-dependent
enzymes, LTP-1 requires activation of PKC via DAG that
is produced after the activation of mGluRs. The activity of
mGluR-PKC is important for both increasing activity as well
as increasing number of AMPA receptors. PKC and CaMKII
then phosphorylate AMPA and NMDA receptors.
Late-LTP. therearetwolaterphasesofLTPnamedLTP-2and
LTP-3.LTP-2requiressynthesisofnewproteinsandreceptors
whereas LTP-3 requires gene transcription. Activation of
adenylatecyclaseandcAMP-dependentactivationofPKAare
required for the formation of the later phases of LTP. LTP-
3 depends on the activation of extracellular signal-related
kinase 1/2 (ERK1/2) and CaM kinase IV, which in turn phos-
phorylate CREB, and this leads to new protein synthesis. p38
mitogen-activated protein kinase (p38 MAPK) is involved in
the formation of long-term depression (LTD), and c-JUN-
N-terminal kinase (JNK) is thought to participate in LTD
[228, 229].
4.1. Disruption of Long-Term Potentiation by Exposure
to Metals in Adults
4.1.1. Calmodulin. Calmodulin (CaM) is a regulatory pro-
tein that is activated by [Ca2+]i. This protein is found
in high concentrations in CNS neurons and is involved
in the activation of several other proteins. Some of the
CaM-regulated proteins that modulate synaptic plasticity
include adenylyl cyclases (AC1 and AC8), protein kinases,
calcineurin, calmodulin kinases (CAMK I, II, and IV), nitric
oxide synthase, and Ca2+ conducting channels. CaM has
four Ca2+ binding sites. Ca2+ binding to CaM leads to a
conformational change that exposes a hydrophobic domain
which enhances the binding of CaM to other target proteins
[226]. It has been hypothesized that in absence of Ca2+, the
concentration of free CaM is regulated by neurogranin that
binds CaM and releases free CaM in response to PKC and
Ca2+ [226, 230, 231]. This important molecule has been
identiﬁed as a target of several neurotoxic metals such as
aluminum, cadmium, and lead.
CaM, when incubated with increasing concentrations
of aluminum (Al3+) (from 0–1000μM), showed decreased
activity. This decrease in activity, measured by the ability of
CaM stimulate activator-deﬁcient cAMP phosphodiesterase
was concentration dependent, [20]. Yet, another study
showed that an [Al3+]: [CaM] ratio of 3:1 resulted in
50% decrease in phosphodiesterase activity, and maximal
inhibition was observed at a ratio of 4:1 [60].
Recently, using highly speciﬁc monoclonal antibodies
that detect the diﬀerent conformational states of CaM and
monoclonal antibodies against Al-CaM complex, researchers
found that on dissolving CaM with AlCl3·6H2O (in increas-
ing concentrations from 0–480μM), the antibody speciﬁc
to Ca2+ calmodulin conformation (the active form) mAb
CAM-1, did not recognize the Al-CaM complex (at Al
concentrations of 240–300μM) indicating that the CaM
was in the inactive conformation. Moreover, the antibodies
against the Al-calmodulin complex were found to bind to
their antigen in the presence of Ca2+. This shows Al binds
CaM, even in the presence of Ca2+, and CaM undergoes a
conformational change into an inactive form. Equilibrium
dialysis and atomic adsorption studies indicated that Ca2+
remained bound to CaM simultaneously with Al. When the
Al-chelator citrate was added to the solution only partial
restoration of CaM activity occurred, suggesting that some
of the Al ions became inaccessible for chelation [62].
The eﬀects of Cadmium (Cd2+) were observed in vivo,
where adult male rats, received 6mg Cd2+/kg body weight
daily for four weeks. Brain CaM activity was determined by
measuring the stimulation of phosphodiesterase activity. AJournal of Toxicology 27
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signiﬁcant decrease in the CaM activity was observed after
Cd2+ treatment. CaM bound to Cd2+ was also detected in the
brains of rats exposed to CdCl2. It was proposed that, since
Cd2+ has an ionic radius similar to Ca2+, it might interact
with the Ca2+-binding sites on the CaM [58, 61].
Lead was also found to interfere with CaM activity in
vitroand in vivo. In vitro incubation of CaM with lead (Pb2+)
increased the activity of calmodulin in terms of its ability to
stimulatecAMPphosphodiesteraseandamaximumincrease
was observed at 30μMl e a dc o n c e n t r a t i o nw h e r e a sa th i g h e r
concentrations the calmodulin activity was inhibited. CaM-
dependent cAMP phosphodiesterase activity increased up to
aconcentrationof100μM,followingwhichtherewasasharp
decline in activity with higher concentrations of lead.T h e
involvement of phenomenon of mimicry of calcium by lead
as a mechanism of toxicity has been proposed. The aﬃnity
of lead to CaM is stronger than that of calcium and lead
can displace calcium from calmodulin [59]. An in vitro study
done on CaM puriﬁed from bovine brain showed that Pb2+
mimics a natural ligand and raises the maximal activation
slightly above the activation by Ca2+ [232].
4.1.2.ProteinKinaseC(PKC). ProteinKinaseCisaCa2+ and
phospholipid-dependent serine/threonine kinase that is a
receptor forDAG and phorbol esters.Therearetwo classesof
PKC. The classical group of PKC consisting of four isozymes:
PKC-α,P K C - βI, PKC-βII, and PKC-γ,a r eC a 2+-dependent
and require Ca2+ as well as DAG or phorbol ester for their
activation. The second group of PKC isoforms consists of
ﬁve isozymes: PKC-δ,P K C - ε,P K C - η,P K C - θ, and PKC-μ.
T h e s ed on o tr e q u i r eC a 2+ for their activation by DAG or
phorbol ester. Various isozymes of PKC are involved in the
formation of LTP. For instance, a null mutation in PKC-
γ prevented the induction of LTP [233]. PKC is activated
postsynaptically when metabotropic glutamate receptors
(mGluR) are activated leading to the formation of DAG
and release of intracellular Ca2+,w h i c ha c t i v a t e sP K C .T h e
mGluR-PKCpathwaythenincreasesthenumberandactivity
of AMPA receptors [224]. The PKC activity is aﬀected by
m e t a li o n ss u c ha sAl3+,P b 2+,H g ,and organic metals such
as methylmercury (MeHg; refer to Figure 5).
Aluminum (Al3+; 0–100μM) decreased in vitro PKC
activity (determined by transfer of 32Pf r o mγ-32P-ATP to
lysine rich histone in the presence of Ca2+ and phosphatidyl
serine), and this eﬀect was concentration dependent [20].
In vivo,r a t sf e daluminum (AlSO4) orally were found to
have more PKC in the particulate fraction of the brain
homogenate compared to the soluble fraction. Normally
PKC is translocated from the cytosol to the membrane when
it is activated. Application of Al3+ caused a 70% increase in
the total activity of PKC resulting in a greater fraction of it
being translocated to the membrane, and hence the presence
of greater fraction of PKC in particulate fraction compared
to the soluble fraction [69].
Lead acetate upon in vitro incubation with PKC from
adult rat brains signiﬁcantly inhibited PKC activity with
an IC50 of 2.12 μM[ 64]. However, it was found that
while very low concentrations of Pb2+ (10−13 to 4 ×
10−4 M) increased PKC activity, higher Pb2+ concentrations
(>4×10−4 M) caused an inhibition of PKC activity. When
recombinant human PKC iso-enzymes were examined, low
concentrations of Pb2+ had very little activating eﬀect on
PKC-γ but inhibited it at higher concentrations (>4 ×
10−4 M) [70]. In vivo, on exposure of adult rats to 1500ppm
lead acetate, there was a decrease in protein expression of
PKCγ by 32% in the cytosol of hippocampal cells and 25% in
the membrane fraction [68]. Another study comparing the
eﬀects of Pb2+ on the PKC in the brain in vivo and in vitro
found a considerable increase in PKC activity in vitro, but
failed to ﬁnd a considerable change in PKC activity in vivo
[234].
In vivo methylmercury chloride administration in rats in
ﬁve doses of 10mg/kg body weight leads to a decrease in
the enzymatic activity of the cytosolic PKC extracted from
the brain, although it did not induce any change in second
messenger binding as measured by binding of [3H]PDBu
[67].
4.1.3. Ca2+/Calmodulin Kinases. There are two types of
Ca2+/calmodulin kinases (CaMK) involved in LTP: CaMKII
and CaMKIV. The Ca2+-CaM complex generally activates
these kinases. CaMKII is a serine/threonine protein kinase
consisting of 12 subunits that are activated when activated
calmodulin is associated with them [235]. Studies have
shown that CaMKII blockers impede the ability to generate
LTP. CaMKII can also be autophosphorylated at Thr286
and its activity becomes independent of Ca2+-CaM. This
autophosphorylation occurs after the formation of LTP. It
is suggested that after activation, CaMKII phosphorylates
the AMPA receptor subunit as well as GluR1 and NMDA
receptors and therefore enhances their conductance [236,
237].
CaMKIV is also activated similarly but the downstream
targets are diﬀerent for CaMKIV. Experiments have shown
that upon activation, CaMKIV can phosphorylate CREB,
which in turn mediates the transcriptional control of protein
synthesis required for the long-term maintenance of LTP
[238].
In vivo, rats exposed to 4ppm arsenic trioxide (As2O3)
for 60 days showed about a 4-fold decrease in expression of
CaMKIVcomparedtoacontrolgroupofratsaselucidatedby
microarray analyses. Western blot analyses reﬂected similar
ﬁndings. Moreover, the decrease in expression of the β-
subunit of CaMKIV was greater than the decrease in α-
subunit expression [77].
4.1.4. Nitric Oxide Synthase. Nitric oxide synthase (NOS) is
an enzyme that produces nitric oxide (NO) by oxidizing L-
arginine using molecular oxygen and NADPH [239, 240].
There are diﬀerent kinds of NOS expressed in several cell
types. Endothelial cells express constitutive endothelial NOS
(eNOS) that is activated by Ca2+. Macrophages express
inducible NOS (iNOS), and its expression is inducible
by cytokines. Neurons express constitutive Ca2+-activated
neuronal NOS (nNOS). Following the activation of NMDA
receptors and the inﬂux of Ca2+, it is believed that nNOSJournal of Toxicology 29
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Figure 6:Moleculesinvolved inthetranscriptionalcontrolofLTPandLTDandeﬀectsofmetals.LTP-3dependsontheactivationofERK1/2
and CaM kinase IV, which in turn phosphorylate CREB, and this leads to new protein synthesis. Other factors such as p38 mitogen-activated
protein kinase (p38 MAPK) are involved in the formation of long-term depression (LTD) and c-JUN-N-terminal kinase (JNK) is thought to
participate in LTD. A green color indicates an activation or an increase, and a red color indicates an inhibition or a decrease.
producesNO,aretrogradesignal,thatdiﬀusesintothepresy-
naptic membrane to enhance presynaptic neurotransmitter
release by the production of cGMP during the formation of
LTP [241, 242].
In vivo, chronic exposure to aluminum (Al3+)r e s u l t e di n
the reduced formation of NO after activation of NMDA in
theratcerebellum,asaconsequenceofdecreasedcalmodulin
and NOS [71].
In vivo arsenic exposure to 37ppm sodium arsenite for
10 days, reduced NMDA-induced NOS activity (as measured
by sampling of extracellular ﬂuid by means of microdialysis).
The maximal NMDA-induced increase of NOS activity (esti-
mated by measuring the changes in extracellular citrulline in
theexposedgroups)wasonly170 ±24%whileundercontrol
conditions it reached 278 ± 27% (P< 0.001) [72].
In vitro incubation of NOS with 100μMo fcadmium
(CdCl2) resulted in a signiﬁcant reduction in brain NOS
activityasmeasuredbytheconversionofradioactivearginine
to citrulline. When incubated, the activity of NOS was
decreased with an IC50 v a l u eo f0 . 2 2m M[ 73].
In vitro incubation of NOS with lead. inhibited NOS
activity with an IC50 of 0.36mM [73]. In vivo, the cNOS
activity in the hippocampus and cerebellum (measured by
citrulline radioactivity following incubation with radioactive
arginine) was decreased in rats that were exposed to 125,
250 and 500ppm lead acetate for 14 days. This decrease
was completely reversible by increasing the free Ca2+-
concentration. The decrease in NOS activity correlated with
blood lead levels [74].
4.1.5. Extracellular Signal-Regulated Kinases (ERK1/2). The
extracellular signal-regulated kinases (ERK1/2) are serine
threonine kinases that are activated when extracellular
signals lead to an increase in intracellular Ras-GTP (GTP-
bound form of Ras). Ras-GTP produced by an increase
in guanyl nucleotide exchange factors (GEF), a decrease
in activity of GTPase-activating proteins (GAPs) or a
combination of both then leads to the activation of the
enzyme MAPK/ERK kinase (MEK). MEK than activates
ERK1 and ERK2 by phosphorylating them. ERK1 and ERK2
(also known as p44 and p42 MAPK) target transcription
factors, cytoskeletal proteins, regulatory enzymes, as well
as other kinases. In the postsynaptic membrane, calcium
inﬂux through the NMDA receptors leads to production
of Ras-GTP that can then trigger the cascade leading to
phosphorylationofERK1andERK2.CREBmaybeoneofthe
targets of the ERK1/2 pathway involved in LTP [229, 243].
CREB, a member of the basic leucine zipper (bZip) family,
is a transcription factor that is responsible for initiating
new protein synthesis for the maintenance of L-LTP. PKA,
CAMK and MAPK can activate CREB by phosphorylation at30 Journal of Toxicology
serine-133.OnphosphorylationotherproteinssuchasCREB
binding protein are recruited to form a complex, which
initiates transcription of CRE containing genes [244–250]
(refer to Figure 6).
Exposure of hippocampal slices of rats to Cd2+ activates
ERK1 and ERK 2 but only at very high concentrations (100–
200μM CdCl2)[ 79, 229].
On incubation of ERK1/2 with 5 μMP b 2+ in vitro for
3 hours, there was signiﬁcant increase in ERK1 and ERK2
phosphorylation in hippocampal homogenates [80].
4.1.6. P38 Mitogen-Activated Protein Kinase (p38 MAPK).
Parallel to the ERK1/2 pathway, which is involved in long-
term potentiation, another MAPK cascade, which involves
p38 MAPK is involved in long-term depression (LTD).
Inhibition of p38 MAPK was shown to inhibit a form of
hippocampal LTD that involved the activation of mGluR.
Inhibition of ERK1/2 by blocking MEK had no eﬀect on
this form of synaptic plasticity. The pathways upstream and
downstream ofp38 MAPKareyet to beelucidated [229,251]
(refer to Figure 6).
Hippocampal slices of postnatal day 14 rats were exposed
to Cd2+ in concentrations between 5–100μMf o r3h o u r s .A
western blot analysis showed that this increased the activity
of p38 MAPK, which is involved in the inhibition of LTP [79,
229].
Incubation of ERK1/2 with 5μM Pb2+ for 3 hours
resulted in a signiﬁcant increase in p38 MAPK phosphory-
lation in hippocampal homogenates [80].
4.2. Disruption of Long-Term Potentiation by Exposure to
Metals during Development. Developmental exposure to
“neurotoxic” metals diﬀers from exposure in an adult in
various ways. The developing brain is more vulnerable
than the adult one. The basic circuitry of the brain is laid
down during development and any disruption of receptors,
neurotransmission, and neurogenesis can prevent the brain
from maturing normally. Inappropriate activation of the
unspeciﬁc receptors in the developing brain can interfere
with the normal “tuning.” Moreover, the blood-brain barrier
is not laid down till approximately six months of age in
humans. This absence of blood brain barrier allows toxic
agents to enter the brain freely and interfere with its develop-
ment. Developmental exposure to metals also raises the issue
of what Costa et al. labeled as “silent” neurotoxicity. This
is when the deleterious eﬀects of various neurotoxic insults
do not manifest until several months or years post-partum.
For instance, in Guam’s disease, unknown neurotoxic agents
cause damage to the CNS, which do not become apparent
until decades later. Here we discuss developmental exposure
of metals and their eﬀects on the molecules involved in the
formation of LTP, which are important for the development
of memory and learning [252].
N-methyl-D-aspartate receptors (NMDAR) are Ca2+
channels, which play an essential role in several forms of
synaptic plasticity (see Section 3.1). They have glutamate
receptors present which are involved in excitatory synaptic
transmission in various parts of the brain. Its unique
p r o p e r t i e s ,s u c ha sM g 2+ block and high permeability to
Ca2+, give NMDAR the ability to contribute to the formation
of long-term potentiation and long-term depression. Several
subunits of NMDA receptors have been identiﬁed: NR1
that is ubiquitously expressed; NR2 subunit family that
has four distinct types (A, B, C, and D) and two NR3
subunits. The expression of the various subunits is diﬀerent
in diﬀerent stages of development. For instance, NR2B and
NR2D expression is present during the neonatal period
and NR2A and NR2C are present in the later stages of
development [253]. Due to its many binding sites (especially
those for divalent cations), which change in their aﬃnity to
their agonists during development, a variety of (toxic non-
physiologic) metals might bind to these NMDAR with a high
aﬃnity and thereby impair their function.
Lead causes impairment of long-term potentiation in
diﬀerent regions of the hippocampus following chronic
lead exposure [254, 255]. This has been associated with a
disruptioninthenormalfunctioningoftheNMDAreceptors
(NMDAR).NMDARcurrentsdecreaseafterinvitroexposure
to 5μM lead in hippocampal cells [152]. This can be
attributed to the observation that Pb2+ alters expression of
the diﬀerent subunits of NMDAR, which has been observed
in the hippocampus and cerebral cortex. Additionally, a
decrease in expression of NR2A subunit mRNA and proteins
in the hippocampus have been seen [56, 57]. Also, the
expression of NR1 subunit mRNA in the hippocampus and
the cerebral cortex of rats increases [57], but this ﬁnding was
not supported by another study by Nihei and Guilarte [56],
which found no change in the expression of the NR1 subunit
protein.
The eﬀects of cadmium (Cd2+) on calmodulin expression
were determined in an in vitro study done on embryonic
rat (ED 15) cerebral cortex, where the cortical slices were
incubated with 10nM cadmium chloride for 24 hours. This
experiment showed a reduced the amount of calmodulin
expression following cadmium exposure [63].
Nitric oxide synthase (NOS) was aﬀected by the develop-
mental exposure of rats to aluminum (Al3+) and lead (Pb2+).
Prenatal exposure of developing rats to aluminum sulfate
(3%) decreased the content of neuronal NOS by 62 ± 12%
in the cerebellum [76].
Perinatal exposure to Pb2+ decreased NOS activity, as
well as NOS expression. Chetty et al., using western blot
analysis of nNOS in developing rat brain after perinatal
exposure to 0.2% lead acetate, found a signiﬁcant decrease
in nNOS protein levels at postnatal day (PND) 21 and 35 in
cerebellum, and at PND 21 in hippocampus [75].
Developmental lead exposure also aﬀected PKC-γ and
CaMKII function. PKC-γ is activated by binding of Ca2+ or
DAG and on activation, it translocates to the membrane.
To determine the eﬀects of Pb2+ on PKC-γ and other PKC-
subtypes, pregnant rats were exposed to 0.1% lead acetate,
dissolved in distilled deionized water (DDW) from gestation
day 6 to postnatal day 21 (PND). With western blot analysis
the expression on PKC-γ was determined. Pb2+ reduced
PKC-γ mRNA expression signiﬁcantly in hippocampus and
frontal cortex at PND 1, 5, and 10, with greater eﬀect on the
membrane PKC-γ than on the cytosolic PKC-γ. AdditionallyJournal of Toxicology 31
there was a decrease in the activity of PKC-γ following
exposure to lead.T h eP K C - γ activity was determined by
measuring the amount γ-32P transferred to histone per
min per mg protein. In the hippocampus and the frontal
cortex,bothtotalandcalcium-dependentPKCactivitieswere
signiﬁcantly inhibited [65].
Moreover, rats exposed to 1500ppm Pb2+ during devel-
opment demonstrated a reduction in the Vmax of CaMKII
(examined by measuring the phosphorylation of a biotiny-
lated substrate for CaMKII) and reduced expression of
CaMKII β subunit in the hippocampus, but showed no
changes in the sensitivity of calmodulin to CaMKII. In other
words, the decrease in CaMKII activity was not due to
impairment in its ability to bind CaM [78].
Various metals also inhibited the enzymes related to the
transcription of new proteins involved in the formation of
LTP. Two such targets are ERK1/2 and CREB.
Prenatal exposure to aluminum sulfate (3%) slightly
increased the content of ERK [76]. Also, in vivo developmen-
tal exposure to 2mg/kg of Pb2+ increased both ERK1 and
ERK2 phosphorylation in rat hippocampal neurons [80].
On developmental exposure to 1500ppm of Pb2+,a
decrease in the amount of phosphorylated CREB was ob-
served in both the hippocampus (25% decrease) and the
cerebral cortex (25% decrease) but there were no signiﬁcant
changes in unphosphorylated CREB levels [81]. Also, signif-
icant changes in the binding kinetics of CREB to CRE were
observed in the hippocampus. The Kd and Bmax both were
decreasedby38%and30%,respectively,inthehippocampus
but no signiﬁcant changes in binding kinetics were observed
in the cortex [244].
4.3. Summary of Long-Term Eﬀects. Metals aﬀect various
mediators of synaptic plasticity. Calmodulin (CaM) activity
is aﬀected by aluminum, cadmium, and inorganic lead.B o t h
aluminum and cadmium inhibited CaM activity [20, 58, 60–
63] whereas inorganic lead ﬁrst increased CaM activity at
lower concentrations (possibly by mimicking calcium), but
then at higher concentrations it decreased CaM activity
[59, 232]. CaM is the central modulator of NMDAR-
mediated synaptic plasticity and a majority of the regulators
of synaptic plasticity depend on CaM for their activation.
Thus, interference with CaM function will indirectly aﬀect
the function of numerous LTP- and LTD-related proteins
such as adenylyl cyclase, Ca2+/Calmodulin kinases, nitric
oxide synthase, and Ca2+ channels [226]. Al3+, Pb2+, and
MeHg aﬀect PKC activity, which is involved in the formation
ofLTP-1.In vitro studiesdemonstratedthatinratbrain,Pb2+
inhibited PKC activity at low concentrations but increased
PKC activity at higher concentrations. However, when
recombinant human PKC-γ was used, an opposite trend was
observed [70]. Exposure to Pb2+in vivo resulted in a decrease
in protein expression whereas MeHg decreasedthe activity of
PKC. Al3+ inhibited PKC activity in vitro but ironically, oral
administration lead to increase in PKC activity [20]. Arsenic
trioxide(As2O3)decreasestheexpressionofCa2+/calmodulin
kinase IV (CaMKIV) with a greater decrease in the β-
subunitthantheα-subunitinvivo[77].Nitricoxidesynthase
(NOS) activity is decreased by various metals such as
Al3+,A s 2+,C d 2+, and Pb2+ [71–73]. The components of
the transcription pathway, p38 MAPK and ERK1/2 were
phosphorylated more when incubated with Pb2+ and Cd2+.
As discussed earlier, P38 MAPK is involved in the induction
of LTD whereas ERK1/2 is involved in induction of LTP-3
[79, 80, 229].
5. Discussion and Conclusion
Most metals act on multiple modulators of synaptic trans-
mission. Heavy metals such as mercury, lead, and arsenic
interfere with normal functioning of molecules both presy-
naptically and postsynaptically. They also target molecules
involved in synaptic plasticity. As discussed above in vivo
and in vitro studies have shown that metals inappropriately
inhibit or activate various molecules involved in synaptic
transmissionandsynapticplasticity.Eventhoughthecurrent
pool of the literature gives us valuable insights into the
mechanisms of metal toxicity at the synapse, there are many
limitations of the current studies.
Firstly, there is hardly any suﬃcient information with
regard to the eﬀect of metals at diﬀerent stages of devel-
opment. Postsynaptically, there is a strong suggestion that
the diﬀerent eﬀects on development are due to diﬀerent
subunit expression. As discussed in Section 3.2, Pb2+ was a
more potent inhibitor of Glu-activated currents in NMDAR
expressing NR2A or NR2B compared to receptors expressing
both these subunits [157]. At the same time, Pb2+ showed
high- and low-aﬃnity components for its inhibition in PN14
and PN21 hippocampal membranes. These data suggested
that the high-aﬃnity Pb2+-sensitive site was associated with
receptors expressing NR2A or NR2B subunits, while the low-
aﬃnity site was associated with receptors expressing both
subunits (to see the eﬀects on other brain areas, review
[153]). The support to this hypothesis came from studies
showing that the developmental pattern of NR2A and NR2B
mRNA in the hippocampus was similar to that in the data
presented [256].
This developmental aspect is not well studied for most of
the metals and also for AMPA/kainate and GABA receptors.
The eﬀects of divalent metals on AMPA/kainate receptors
seem to be dependent upon the subunit composition as well,
particularly the presence of GluR2 subunit which rendered
the channel impermeable to Ca2+. Zn2+ and Co2+ both had
dual eﬀectson AMPA-Rs: atmicromolar concentrationsthey
enhanced AMPA receptor responses whereas at millimolar
concentrations, they had inhibitory actions. Various metals
caused inhibition of Ca2+ impermeable AMPA-R, the inhibi-
tion was fast, reversible, and voltage independent. The rank
order of activities was Ni2+ > Zn2+> Co2+> Ca2+> Mn2+>
Mg2+ [190]. The proposed mechanism of action was that
complexes of AMPAR agonists and divalent cations compete
with the free agonists for the binding sites.
Prenatal exposure to heavy metals also leads to various
changes in the LTP machinery in the developing brain as
discussed before. Lead, for instance, changed the expression
pattern for NMDAR subunits, and decreased the expression32 Journal of Toxicology
and activity of PKC-γ,C a M K I Iβ, and nNOS in various
areas of the brain. These results could explain why the
development exposure to some metals causes cognitive
deﬁcits in children.
Moreover, a majority of the studies were done in vitro,
and the in vivo studies were done in rats. In most in
vitro studies, either brain homogenates or puriﬁed target
molecules were incubated with a given metal. These studies
therefore may not accurately depict the physiologic eﬀects
of the metals since they do not undergo the physiological
p r o c e s so fa b s o r p t i o nf r o mt h eg u ta si nt h eh u m a nb o d y ,
and the alterations that may occur in the blood before the
metals reach the target tissue. Also, the solutions used for the
preservation of the cells may interfere with the experimental
results rendering them inaccurate. Moreover, the contents of
the media and the forms of metals used were inconsistent
between studies. Consequently properties such as solubility
of metals in the media and presence of anions and pH were
variable and beyond the scope of this study to discuss. It
is deﬁnitely a limitation of in vitro studies, which makes it
diﬃcult to compare the diﬀerent experiments, even when
an identical concentration of the same metals was used.
However, the ease of carrying out the experiment and lack of
requirement for storage space for animals make them a likely
choice for most researchers. In vivo studies may be closer to
the physiologic processes; however it becomes harder than to
vary the concentrations of metals and monitor them at the
selected site of interest.
In addition, most of the ﬁndings presented in this review
both in vivo and in vitro were based on studies done using
rats. Even though it is easy to measure concentrations of
metals, levels of proteins and enzymes in rats, elucidating the
clinical manifestations in animal models can be challenging.
Also,itishardtoﬁndwhethertheeﬀectsinratsaresimilarto
those in humans and if the eﬀects in rats are representative of
the eﬀects in humans. Higher cognitive functions in humans
might alter the presentation of the toxicity in ways that
cannot be adjusted for because much of the mechanisms of
the functioning of the human nervous system are not fully
understood today.
Another important limitation of the currently available
literature is that the majority of studies discussed were
on eﬀects of inorganic metals on the brain cells or brain
molecules, and very few centered around organic metals
which are perhaps even more signiﬁcant than inorganic
metal toxicity since in some cases the organic forms are
more toxic than the inorganic forms, as for mercury [257].
There is a rapidly growing body of evidence that the majority
of metals may actually be methylated to their organic
form as the body attempts to detoxify metals. For arsenic,
in the past it was believed that conversion of arsenic to
monomethyl arsenic and dimethyl-arsenic was a method of
detoxiﬁcation; however, the view has changed since then
with the recognition that methylated metabolites of trivalent
arsenic are carcinogenic [258]. Antimony, mercury, lead, tin,
and selenium are known to cause public health problems in
theirmethylatedforms.Cadmium,cobalt,mercury,andnickel
reportedly undergo biomethylation; however, the eﬀects
of biomethylation have been studied more in unicellular
organisms rather than plants and animals, therefore it has
been suggested that although biomethylation does occur in
plants and animals, the rates are likely to vary on the basis of
the animal and the metal, and its concentration [259].
There are some situations that have not been considered
inmostexperimentaldesigns.Onesuchissuethatariseswith
the study of metals is the problem that most studies are not
reﬂective with regard to the actual exposure in nature where
humans are simultaneously exposed to more than one metal.
V e r yf e ws t u d i e sh a v et a r g e t e dt h i si s s u e ,m o s tl i k e l yd u et o
the complicated nature of conducting an experiment with
many variables and determining the contribution of each.
One study by Platt and B¨ usselberg who examined the eﬀects
ofcombinationsofPb2+,Zn2+,andAl3+,onvoltage-activated
calcium channels by simultaneous application of various
combinations of two metals determined that regardless of
the order in which the metals were added, the actions
were in fact additive [260]. Whether this is the case with
other metals is not certain and there is not enough data in
the literature describing eﬀects of combinations of metals.
Another limitation of the study is that some targets may not
be as relevant as others in causing the clinical symptoms of
metaltoxicity;however,itisnotpossibletoknowatthisstage
the exact contribution of each target.
Finally, the most important objective is to put these
eﬀects of metals into practical use. This can be done by
using the data of the toxic concentrations of metals to make
a meaningful decision in regard to their acceptable blood
levels. There is evidence to suggest that currently accepted
levels for some metals are still not “safe” levels. Even at
the currently accepted blood lead levels of 10μg/dL, it is
causative of preterm labor and adverse pregnancy outcome
[261]. Therefore, there is a need to reevaluate the accepted
blood concentrations of metals in light of the newer evidence
as it appears.
Metal neurotoxicity is a ﬁeld, which is abounding with
the literature and excellent research; however, in the current
literature some metals are highlighted while for other metals
(or metal compounds) hardly any data are available. There is
an emphasis on certain metals such as lead, whose harmful
eﬀects are well known while there is very little known about
certain metal groups such as lanthanides and actinides.
There are certain targets where metal actions have been
excessivelyexaminedsuchasvoltage-activatedcalciumchan-
nels while there is little known about the eﬀects of metals on
parts of signaling pathways such as phosphodiesterases and
IP3. This raises the need to evaluate new targets for metals,
whichhavenotbeenstudiedbefore,whichmayprovetohave
a groundbreaking eﬀect in the ﬁeld of neurotoxicity.
To summarize, exposure to diﬀerent metals occurs
due to industrial activities, environmental, and food chain
contamination. This paper elucidated the various targets
of metals in synaptic transmission and synaptic plasticity.
Exposure to metals had varied eﬀects on diﬀerent synaptic
targets, which were dependent on the form of metal, the
concentrationofmetal,routeofexposure(invitroorinvivo),
themediumused,andeventhedurationofexposureinsome
cases.Journal of Toxicology 33
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